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Some time ago, it became apparent to scientists at 
the Goddard Space Flight Center that the ability to 
make images of celestial objects in the X-ray and 
gamma ray regions of the spectrum would be impor- 
tant to astronomy in the future, much as the ability to 
make an image in the visible region using ordinary 
photographic techniques is important today. It was 
this interest in the imaging of hard X-rays and soft 
gamma rays that led to the development of a low 
intensity X-ray imaging device, known as the Lix- 
iscope, by Dr. Lo I Yin of Goddard's Science Staff. 
Soon after Dr. Yin began its development, it became 
clear that the Lixiscope would have uses beydnd the 
purely scientific. Recognizing these potential uses, he 
first presented the Lixiscope concept at the American 
Nuclear Society meeting in San Francisco in 
November 1977. Since that time, interest in the 
device has been very strong in areas of non-space 
applications. 
During the past year, a number of highly qualified 
medical institutions have conducted preliminary 
evaluations of the Lixiscope to determine the 
usefulness of the device in various applications. 
These applications include: 
* Orthopedics 
@ Dental Research 
* Podiatry 
* Maxillo-Facial Diagnosis 
a Pediatrics 
a Veterinary Medicine 
On July 27 and 28,1978, a conference was held at 
the Goddard Space Flight Center to present the 
preliminary results of these evaluations. The con- 
ference provided an opportunity for the discussion of 
future possibilities, future improvements, and future 
applications. 
In the following paragraphs, summary descriptions 
of these preliminary results are given, along with a 
discussion of the concept of the Lixiscope; its com- 
parison with other X-ray imaging devices; informa- 
tion regarding the use of the device, patent policy and 
licensing, and radiological regulations; and some 
contemplated improvements to the prototype 
Lixiscope. 
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THE- LIXISCOPE 
A. THE LiXISCOPE CONCEPT 
Dr. Lo i Yin 
Laboratory for Astronomy and Solar Physics 
Goddard Space Flight Center 
The principle of the Lixiscope is extremely simple. 
(Figure 1 ) It is based on a modular approach toward 
X-ray imaging where the three major components are 
physically independent entities, and therefore easily 
replaceable and interchangeable. The three major 
components are: the X-ray source, the converter 
phosphor or scintillator, and the microchannel plate 
visible-light image intensifier. The X-ray image of an 
object formed by the X-ray source falls onto the 
converter phosphor or scintillator which converts 
the X-ray image into a visible-light image. This 
visible-light image is then intensified by a factor of 
1 0 5  or more by a high-gain microchannel plate 
visible-light image intensifier whose output ca/n be 
viewed directly, photographed, or coupled to other 
imaging devices. Because of the high gain of the 
microchannel plate image intensifier, it is possible in 
some applications to use a radioactive source instead 
of an X-ray machine. In this manner, the whole X-ray 
imaging device becomes completely portable. 
In the Lixiscope prototype, a "point" radioactive 
source is inside a shielded source holder. (Figure 2)A 
finger-controlled mechanism unshields the source to 
collimate the radiation onto a converter phosphor 
which is shielded from ambient light, but is optically 
coupled to the night vision image intensifier. Because 
of the source collimation and two layers of lead glass 
in the intensifier, no significant radiation above 
natural background reaches the viewer. The Lix- 
iscope is powered by a single 2.7 volt battery in  the 
handle. 
Since its  inception, there has been a large interest 
in the Lixiscope. Because of its small size and port- 
ability, there are many potential medical and 
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Figure 1 .  Principle of the Lixiscope 
Figure 2. The Lixiscope Prototype 
industrial applications. During the past year, experts in 
some areas of medicine and medical physics have, on 
a rather limited scale, tested the prototype Lixiscope. 
The preliminary impressions and evaluations of the 
potential applicability, advantages, limitations, as 
well as shortcomings of the Lixiscope in  the respec- 
tive fields are described in this report. There have not 
been any formal large-scale clinical evaluations of 
the Lixiscope. This conference can be considered only 
as an initial effort in  this direction. 
To put the Lixiscope in its proper perspective, the 
following characteristics should be considered. 
1. The Lixiscope is a small-sized, fully portable 
fluoroscope.1-4 As such, its most promising 
applications are likely to be in those situations 
where large size is not important but portability 
is, such as where electricity is not available or 
where easy maneuverability is necessary. 
Therefore, it wil l  not replace or duplicate the 
functions of existing X-ray imaging devices, 
which are large-sized and non-portable. There 
are areas of overlap where the Lixiscope can 
serve as a complement to the larger instrument. 
When performance characteristics such as im- 
age quality and dose rates associated with the 
Lixiscope are considered, one should take into 
account the specific manner i n  which it is to be 
used. In this regard, publications may have been 
misconstrued by implying that the Lixiscope is 
the only low-dose imaging device, or that it can 
achieve dosage reductions of 1 0 3  times in  all 
applications. This is not the case. There are 
other existing devices and methods which have 
equal performance characteristics at low-dose 
levels comparable to the Lixiscope. However, in  
fluoroscopy, the Lixiscope not only achieves 
these performance characteristics simply and 
efficiently, but also in an extremely compact, 
rugged, and fully portable manner. Small, port- 
able fluoroscopy is the most important char- 
acteristic of the Lixiscope. 
Because the Lixiscope is essentially a fluo- 
roscopic device for real-time X-ray imaging, the 
best way to Dresant the real-time images 
would b; in  the'form of a movie or a video tape. 
However, in  the accompanying photos, the 
fluoroscopic images were recorded on instant- 
processing film. As such, they are not direct X- 
ray radiographs, and should not be compared 
with the resolution and quality of X-ray 
radiographs. 
4. The prototype Lixiscopes used for these 
evaluations were constructed entirely from off- 
the-shelf items. No effort was made to optimize 
their performance for a given application. 
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B. FUTURE PROGRESS 1N THE DEVELOPMENT OF THE LIXISCOPE 
Jacob I. Trombka 
Solar Activity Branch 
Goddard Space Flight Center 
It was GSFC's interest in the imaging of hard X-rays 
and soft gamma rays that led to the development of 
the Lixiscope. High spatial resolution imaging devices 
capable of single-photon counting in this energy 
domain of the electromagnetic spectrum will find 
important applications in the fields of astrophysics, 
solar physics, planetary physics and in studies of 
weightless effects in the space environment. The 
directions that the research in the GSFC laboratory 
will take in the future development of the Lixiscope 
with respect to these objectives are summarized 
below. 
The end-point in the research related to the in- 
vestigations in astro-, solar, and planetary physics is 
the development of a hard X-ray/soft y-ray tele- 
scope. It is hoped to use the Lixiscope as a position- 
sensitive detector placed at the focal plane of such a 
focussing or collimating X-ray/ y -ray telescope. The 
Lixiscope properties which are important and need to 
be developed for such a focal-plane device are single- 
photon counting with the capability of energy 
sensitivity as far into the y-ray region as possible. 
GSFC has demonstrated the pulse-counting capabili- 
ty as well as simultaneous pulse counting and posi- 
tion sensitivity. These methods are described in the 
Reference, where the limited pulse-height, or energy 
resolution of a proto-type high-gain microchannel 
plate (MCP) tube, is also described. A number of 
different scintillators are now being tested in order to 
extend the Lixiscope energy sensitivity. The scin- 
tillator of specific interest is Csl. GSFC is also looking 
at cellurized scintillator screens which may improve 
spatial resolution at higher y-ray energies. 
GSFC is not presently involved in developing X-ray 
and y-ray optical systems, but hopes to use the 
results of recent research in this field. Both collimator 
and pin- hole systems show great promise for apptica- 
tion in the development of a gamma ray telescope. 
Fan-shaped collimators might be used to study 
spatially extended sources. However, collimators are 
rather limited in terms of mapping large regions of the 
sky. Pin-hole camera approaches permit mapping of 
larger regions with good spatial resolution. Single 
pin-hole systems reduce the flux at the focus of the 
imaging detecting device (possibly the Lixiscope) to 
such an extent that extremely long counting times 
would be required to obtain statistically significant 
results. On the other hand, multiple pin-hole systems 
(the Dickey Camera) are capable of focusing images 
with about 30 percent transmission of the incident 
flux. Rather complex mathematical methods are re- 
quired to reduce image confusion due to the multiple 
pin-hole optical system. Both digital and analog 
methods are being used to perform the required 
mathematical transformations. 
Finally, many of the phenomena to be studied are 
time dependent. The excellent time resolution of the 
Lixiscope detector shou Id be ideally suited for such 
studies. The time resolution should only be limited by 
counting statistics. 
In studies of biological effects due to weight- 
lessness (Zero-g), the Lixiscope would be used as a 
fluoroscope. An example of such a study is theobser- 
vation of the increased inter-costal spacing during 
weightlessness. This effect is most dramatically 
demonstrated by the fact that the astronauts become 
about 3 inches taller during space flight. This growth 
may be attributed to the increase in inter-costal 
(space between bones) spaces during space flight. 
This effect in small animals may be studied with the 
Lixiscope during some of the Space Shuttle flights. 
The general effect on skeletal structure due to cal- 
cium demobilization can also be studied. Growth 
phenomena in zero-g and away from wall effect can 
also be studied. 
Based on the foregoing discussion, it is indicated 
that the Lixiscope has various applications to the 
basic problems in space research. The Laboratory for 
Astronomy and Solar Physics is planning a research 
and development program in which those properties 
of the Lixiscope most applicable to space flight 
research will be studied and explored. 
I Reference 
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y-Ray Imaging Detectof', Space Science Instrumentation 
(In press), 1979. 
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C.  THEORET1CAL CALCULATIONS & INSTRUMENT 
DEVELOPMENT & TEST 
CHARACTERIZATION OF LOW INTENSITY X-RAY IMAGING DEVICES 
Dr. George Ferguson, Marshall Lewis, Rajinderbir Harnal 
Howard University 
Dr. Javan Anderson. Ms. Sandra Brown 
Howard University Hospital 
The search for a high resolution imaging device to 
detect electromagnetic radiation in the 20 Kev to 300 
Kev energy range lead researchers at the National 
Aeronautics and Space Administration (NASA) to the 
development of the Lixiscope (acronym for Low Inten- 
sity X-ray Imaging Scope). A detailed description of 
the component parts and the principle of operation of 
this unique instrument is given elsewhere.' The 
device is essentially the combination of a scintillator 
to convert impinging X-rays to visible light; a photo- 
cathode to produce an electron image; a multi- 
channel plate (MCP) to intensify the electron image; 
and a phosphor screen to reconvert the intensified 
image to visible light. Fiber optic plates, which are 
employed to transmit images between component 
parts, prevent degradation in resolution of the image. 
Radioisotopic sources have been used* to excite the 
Lixiscope in preliminary experimental attempts to 
evaluate the usefulness of this instrument for in- 
dustrial and medical applications. The purpose of this 
study is to explore the characteristics of the Lixi- 
scope when excited by X-rays produced by conven- 
tional electrically powered X-ray generators. The 
broad goal is to determine the optimum X-ray spec- 
trum, and mode of operation of the generator, which 
yields satisfactory LixiScope images of medical and 
industrial specimen. 
EXPERIMENTAL PROCEDURE 
X-RAY SOURCE 
C BIOLOGICAL 
SHIELD U N a I I T g ,  DETECTOR 
-TOPHA 
Figure 4 .  Diagram of Experimental Arrangement 
used for Lixiscope Investigation 
The photon energy distribution of this source, 
shown in Figure 3, was experimentally measured 
using a two-inch Na l (TI) scintillation detector 
arranged as depicted in Figure 1. The energy scale for 
Figure 3 was obtained using radioisotopic sources 
whose radiations are well known.3 
The experimental arrangement employed with the Image Standards 
Lixiscope is shown in Figures 1 and 2. Exposures of selected specimen were obtained 
using a standard medical radiographic unit*. The 
specimen were placed above, and in direct contact X-Ray Source with, an 8" x 10" film cassette, then irradiated using 
The source of radiation used to excite the Lixiscope standard techniques employed by radiologists. The 
is a radiographic inspection system (Faxitron Model specimen selected were (a) a skeletal hand, (b) a 
. 8050-31 0, manufactured by Field Emission Corpora- portion of a finger of an Alderson phanthom ~at ient  
tion, McMinnville, Oregon). This self-rectified X-ray and (c) a composite wire. The composite wire con- 
system produces a continuously variable output sisted of a small diameter(0.062" 0.d.) inconel tube in 
range is 0-1 30 kvl with a maximum 
"Medical Radiographic and Fluoroscopic Unit (manufactured by 
current of 3 ma. The X-ray spot size is 0.5 mm. Picker Instrument Corp.), focal point spot 1.4 mm. 
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Figure 6. Image of a Composite Wire using a 
Medical Radiographic Unit 
Figure 8. lrnage of an Alderson Phanthom Finger 
using the Radiographic lnspection System 
(Faxitron) 
and 9 are images of the specimen obtained in the 
same manner as above, except that the radiation 
source used was the Faxitron x-ray generator to be 
employed in the Lixiscope study. A moderate 
increase in resolution is seen due to the smaller 
(0.5 mm) spot size for this generator. 
Camera Recording System 
Photographic images were obtained using a CU-5 
Polaroid Close-Up camera (75 mm focal lens at f/4.5, 
2x magnification). Measurements indicated negligi- 
ble darkening of film due to direct exposure to X-rays 
in the experimental arrangement shown. 
Lixiscope Images 
Having ascertained that high quality radiographic 
images are achievable using the Faxitron X-ray 
system and that sharply focussed photographs (free 
of background fogging) can be obtained with the 
camera employed, the Lixiscope images were ob- 
tained of specimens (a), (b) and (c) as given in Figures 
10, 1 1 and 12. The resolution of these images is 
deemed -to be acceptable and the Lixiscope could 
become a useful diagnostic instrument. 
Further Studies 
The preliminary measurements given above have 
encouraged us to plan further studies of the 
characteristics and utility of the Lixiscope. Our plan is 
Figure 7. lrnage of a Skeletal Hand using the to study the response of the Lixiscope as the incident 
Radiographic Inspection System (Faxitron) spectral distribution is varied, that is, as the character 
Figure 9. lmage of a Composite Wire using the Radiographic inspectiow System (Faxitron) 
Skeletal Hand (Po@ion of index Finger Only) Figure 12. Photsaraph of Lixiscope Image sf a 
Figure 11. Photograph 0% Lixiscope lmage of an 
Alderson Phanthom Finger (Portion of lndex Finger 
Only) 
~ o m i o s i t e  Wire 
and magnitude of the incident radiation is changed. 
We shall further attempt to investigate the response 
of the Lixiscope when excited by monochromatic 
radiation (energy range 20-100 Kv) using an X-ray 
diffractometer available to us. From these studied we 
wil l  determine the optimum X-ray spectrum 
recommended for several categories of specimen 
being analyzed (i.e. medical specimen, industrial 
specimen, etc.). In addition, we wil l  investigate the 
preferred mode of operation of the X-ray generator 
(i.e. continuousvs. pulsed)which minimizes radiation 
dose to the specimen and the energy consumed in the 
operation of the X-ray generator. 
REFERENCES 
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X-RAY SOURCE CHARACTERISTICS AND DETECTION EFFICIENCIES 
OF PROTOTYPE LIXISCOPES 
Stephen M. Seltzer 
Center for Radiation Research 
National Bureau of Standards 
The most compact, portable arrangement of the 
Lixiscope consists of: (a) an X-ray-emitting radioac- 
tive source; (b) at some distance away, a scintillator 
. 
screen, used to convert the X-ray image into a visible 
light image, which is coupled to (c) a microchannel- 
plate, visible-light, image-intensifier tube. 
The devices used in  the early feasibility study 
reported here are prototypes, whose performance 
characteristics have neither been comprehensively 
evaluated nor optimized. This paper will concentrate 
on the radioactive X-ray sources and scintillator 
screens used in our prototype units. This discussion 
will highlight some of those considerations.necessary 
for the optimization of future Lixiscope designs, as 
well as provide some semi-quantitative information . 
on the present prototype devices. 
shell fluorscence efficiency of 0.9184 for the '53Eu 
daughter atom. 
For estimating the reduction factor due to self- 
absorption in the source and attenuation in  capsule 
windows, the following simplified model was used: 
(a) the active source volume was assumed to be a 
homogeneous, right-circular cylinder; (b) all photons 
were assumed to travel in a direction parallel to the 
cylinder axis and to cross perpendicularly through the 
window material; (c) scattering of photons was 
neglected. Although assumption (b) appears quite 
drastic, keep in mind that we are ultimately interested 
only in that portion of the emitted beam, tightly 
collimated about the source axis, in which the 
photons are nearly parallel to the axis. Concentrating 
all of the photons in that direction results in 
Radioactive Source "effective" point-source emission data, and allows the usual factor 1 /47r to account for the isotropic Success has been achieved with two commercially nature of the intrinsic emission. 
available radioactive sources, 1 2 5 1  and 153Gd, which With these assumptions, it can easily be shown 
decay by electron capture and which have emission that the reduction factor is given by 
spectra that appear to be particularly suitable for 
medical and dental diagnostic use. The 1251 sources 
were supplied by the Amersham-Searle Corp." in 
their standard point-source configuration; the 153Gd 
source was obtained from the Oak Ridge National 
Laboratory. In order to estimate the radiation 
emission characteristics of these finite, encapsulated 
sources, we must know the energies and intensities 
of radiation emitted by a single atom, and then correct 
for the effects of self-absorption in the finite source 
volume as well as attenuation in the source capsule 
window foils. 
Radiation energies E and intensities n (probability 
per decay) are given i n  the first two columns of 
Table 1 for the decay of single atoms, for both 1251 
(60.1 day half-life) and 153Gd (242 day half-life). The 
data for lZ5l were obtained from Reference 1, wi th 
some auxiliary information on energies2 and relative 
intensities3 of the X-rays emitted by the daughter 
725Te. For 153Gd, the data were extracted from the 
Evaluated Nuclear Structure Data File (maintained by 
the Nuclear Data Group at the Oak Ridge National 
Laboratory), using auxiliary X-ray data2e3 and a K- 
*Commercial identification in these discussions is only for the 
purpose of uniquely specifying components used, and does not 
imply any recommendation or endorsement by any agency of the 
U.S. Government. 
where p, and U, are the photon total attenuation 
coefficients (for the photon energy of interest) for the 
source material and window materials, respectively, 
and where ts  and t, are the thicknesses of the source 
and windows, respectively. Using data on p from 
standard references5-7, estimated emission inten- 
sities, n '  = fn, for the finite, encapsulated sources 
considered are given in the last column of Table 1. 
From the data in Table I, the average photon energy 
emitted by 1Z5 l  is -28 keV; and for l53Gd, the average 
energies are -43 keVfor the X-rays; and - 100 keVfor 
the gamma rays. 
Under the assumption that the source is a point 
source, we can then easily estimate the photon flux+ 
and exposure X at a distance r from the source: 
4 = 2.94 x 106 NA/r2 
X = 0.0543 DA/r2, 
where + is in cm-2sec-1, X is in mR sec-1, r is in  cm, 
and A is the source activity in mCi. In the above 
equations, the parameter N is the mean number of 
photons per disintegration that penetrate to distance 
r and is given** by N nIi exp(-pir), where the 
I 
summation is over the photon energies of interest, 
**We have neglected scattering in the air. 
Table 1. Estimated Radioactive Source Emission Characteristics* 
Mean number of photons per disintegration 
Energy Single Effective point-source values 
(keV) atom for finite, encapsulated source 
Gamma ray: 
K X-rays: 
Gamma rays: 
"For l251,  based on an approximate estimate of self-absorption in 7 - 
rnrn diarn. x 1 -mrn thick C (density= 7.5 g/crn3), and attenuation in 
a 0.5-rnrn Be capsule end-face (density = 1.85 g/crn3) and a 5-prn Ti 
window (density = 4.5 g/crn3). 
For l53Gd. based on an approximate estimate af self-absorption in 
and ,u is the photon total attenuation coefficient in air. 
D is effectively the air kerma per disintegration due to 
photons that penetrate to distance r, and is given by 
D = nl, Ei pien exp(-pir), where A,, is the photon 
mass energy-transfer coefficient in air. 
For the energies and distances of interest, we can 
neglect the attenuation in air and find 
N D 
Using these results, estimates of the photon flux 
and exposure produced by sources of 50 mCi '251 and 
200 mCi 153Gd are given in Table 2. The ap- 
proximations made in obtaining these results make 
their reliability somewhat uncertain. We note, 
however, that exposure measurements made on 
these sources with field survey instruments agree 
with the predictions to within about 30%.* 
The lower limit of the detected X-ray flux for which 
an imaged object can be recognized (the so-called 
quantum limit) is somewhat subjective, and depen- 
7-rnrn diarn. x 1.6-rnrn thick Gd203 (density 5.2 g/crn3), and 
attenuation in a 10-mil A Q  window (density = 2.7 g/crn3). 
L X-rays,' heavily absorbed in finite encapsulated source, are 
assumed absent. 
dent on a number of factors which can vary greatly 
according to the task. As a guideline we can borrow 
an illustrative example used elsewhere*: a high- 
contrast, 0.1 -mm object (5 Q p/mm) whose quantum 
limit for real-time viewing is - 105 cm-2sec-1. Then 
consider this object behind -5 cm of tissue, at a 
source-to-skin-distance of r= 2 cm.** For an attenua- 
tion factor of -0.2 due to the tissue and a detection 
efficiency of -0.5, we need an incident flux of 105 (7 
cm/2 cm)2/(0.2~0.5) = - 107 cm-2sec-1 for the high- 
contrast object. A more difficult task might require a 
flux of, say, - 108 cm-2sec-1. We seefromTable 2 that 
we are just in this range with the present sources; 
that is, we are operating close to quantum limits. 
Scintillator Screen 
The detection efficiencies (the fraction of incident 
photons which suffer an interaction) for two scin- 
tillator screens are shown in Figure 1 as a function of 
photon energy. The rare-earth curve is representa- 
tive of the Kodak Lanex Regular single screen used 
in the prototype device. The Csl curve corresponds 
to an -180-pm Csl screen which has not yet 
been successfully tried. The curve for a bare X-ray 
film is included for reference. Indicated by arrows in 
* These discrepancies may indicate a fauEty char8cterization of the **A plastic spacer might be attached to the source holder 
source matrix Keep in mind also that the activity specified for the to insure r 1 2 cm, in order to keep the skin exposure at 
commercial sources were nominel values tolerable levels. 
PHOTON ENERGY, keV 
Figure 1. Detection Efficiency for Scintillator Screens, as a Function of Photon Energy. Energies of the 
photon components emitted by lZ5l and by 153Gd sources are indicated. The "rare earth" curve pertains to 
55 mg/cm2 of Gd202S behind 3 0  mg/cm2 of C. The Csl curve corresponds to  80 mg/cm2 of Csl behind 
10 mg/cm2 of A2. The curve for film. 7 mg/cm2 of AgBr, is shown for reference. 
Table 2. Estimated Photon Fluxes and Exposures from the Radioactive Sources* 
*For 153Gd, the exposure includes contributions from both the X- and gamma rays; the flux values include only the 
diagnostically useful X-rays. 
Figure 1 are the energies of the -28 keV X-rays from 
the 1251 source and the -43 keV X-rays and -100 ke\l 
gamma-rays from the 153Gd source. 
For the 1251 source, the detection efficiencies of the 
rare-earth screen and the proposed Csl screen are 
both -55%. Forthe 153Gd-source X-rays, the detec- 
tion efficiency of the Csl screen (-80%) is roughly 
three times greater than that of the rare-earth screen 
(-25%). Also, for the case of the lE3Gd source, the 
Csl screen has the advantage that it detects the 
diagnostically useful 43-keV X-rays about 5 times 
more efficiently than the 100-kevgamma-rays which 
carry little information, and thereby constitute a 
background. 
Because of the very high spatial resolution of the 
microchannel-plate intensifier tube, the resolution of 
the Lixiscope is largery governed by the resolution of 
the scintillator screen. Rough figures of merit can be 
estimated from available literature on modulation 
transfer functions (MTF's). The limiting resolution is 
sometimes defined as the frequency(~p/mm) at a 
modulation transfer of 0.04-0.05. Then, for the rare- 
earth screen, the resolution can be estimated9 to be 
-4 Qp/mm, which is consistent with our obser- 
vations. For a 180-pm mosaic Csl screen, the 
resolution may be expected10 to be in the region of 
2-3 Q p/mm. 
Other factors will affect the overall resolution of the 
system. For example, a finite-source spot size, a short 
source-to-object distance, and a non-negligible 
object-to-detector distance can combine to produce a 
significant penumbra and, consequently, a blurring of 
the image. In addition, eye blur in viewing the output 
image can reduce the apparent resolution. For this 
reason, magnifying the output image should improve 
its sharpness. 
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SOME CONTEMPLATED IMPROV-EMENBS TO T H E  PROTOTYPE LlXISCOPE 
Dr. Lo I Yin 
Solar Activity Branch, Laboratory 
for Astronomy and Solar Physics 
Goddard Space Flight Center 
The evaluation of the prototype Lixiscope, con- 
structed entirely from easily available components, 
shows that many improvements can and should be 
made. The purpose of this paper is to describe some 
contemplated improvements. These can be divided 
roughly into two categories: those which are well 
within existing technology, and thus can be im- 
plemented immediately; and those which are more at 
the state-of-the-art level, and which are directly 
related to applications in X-ray and gamma ray 
imaging in astronomy. 
OBVIOUS IMPROVEMENTS WITHIN 
EXISTING TECHNOLOGY 
Size 
As many people have pointed out, it is highly 
desirable to have a larger format microchannel plate 
(MCP) intensifier without sacrificing the portability or ' 
the maneuverability of the Lixiscope. A larger size will 
help significantly in terms of orientation and the ease 
of examination. The present prototype uses a 25-mm 
diameter MCP. The next available size of the MCP is 
40 mm in diameter. Unfortunately we have not been 
able to obtain one, although they do exist. An 
alternative way to achieve a larger format is to use 
tapered fiber optics. For example, if 2:l tapered fiber 
optics are used with the 25-mm MCP intensifier, 2:1 
in the front and 1 :2 in the back, thiseffectively gives a 
50-mm diameter Lixiscope. Given the present X-ray 
phosphor and MCP intensifier, there will be little or no 
degradation in resolution as a consequence of the 
additional tapered fiber optics. This is because the 
limiting resolution of 4 line pairs per m'm (Ip/mm) of 
the prototype is governed by the rare-earth phosphor 
converter. The inherent resolution of the MCP image 
intensifier for visible light is about 30 Ip/mm. 
Therefore, as long as the fiber size in  the large- 
diameter end of the tapered fiber optics remains 
much smaller than the resolution limit of the 
phosphor converter and the resolution in the minified 
end is still well within the capability of the MCP 
intensifier, there will be little or no loss in resolution. 
- 
These conditions can be easily met by the available 
tapered fiber optics. The slight loss in intensity dueto 
additional transmission through the fiber optics can 
be compensated for by the intensifier gain. Note that 
there will be no loss in detection efficiency because 
this is still governed by the same phosphor converter. 
The resultant object-to-image ratio in this case is 
again $1 :l. In those instances where magnified 
images may be advantageous, they can also be 
achieved through tapered fiber optics instead of 
lenses. 
Non-Inverted image 
The image from the inverter MCP intensifier tube 
used in the prototype is a source of inconvenience 
and mild annoyance. This can be eliminated by the 
use of a "wafer" MCP intensifier which is currently 
available and does not have an electrostatic inverter 
lens. Furthermore, the wafer tube decreases the 
thickness of the entiredevice to about 1.5 cm, making 
it more compact. However, wafer tubes in  general 
have lower gain than inverter tubes, so that the 
resultant image is much dimmer at the same input 
flux. This can be remedied by the method described in 
the next paragraph. A 1 80° twisted fiber optics plate 
can also be attached to an inverter tube to provide a 
non-inverted image. 
Brightness 
At present, an automatic brightness control (ABC) 
circuit is included in the standard power supply of 
night-vision MCP intensifiers. This protective feed- 
back circuit senses the output phosphor current such 
that when it reaches a predetermined value the gain 
of the MCP is decreased by reducing its operating 
voltage, thereby preventing possible tube damage 
due to accidental overexposure. When a radioactive 
source of a given activity is used as the X-ray source 
there is no danger of overexposure to the intensifier. 
Readjusting the ABC, or disabling it, will allow the 
intensifier to operate at maximum gain and possibly 
brighter output. However, the maximum gain of 
standard night-vision MCP intensifiers is limited by 
the length-to-diameter ratio (L/D) of the micro- 
channels (about 40:1), and the onset of ion- 
feedback noise and oscillations. In this regard, the 
electrostatic inverter lens serves as an ion trap, and 
thus enables the inverter tube to achieve higher gain 
than that of wafer tubes with the same L/D MCP. This 
maximum gain still may be insufficient to provide 
enough brightness for operation near the quantum 
limit of a low X-ray flux. To remedy this situation, but 
keeping also within the confines of readily available 
technology, one could use two wafer tubes in 
cascade, or one MCP wafer tube followed by a diode 
intensifier, to achieve higher gain and brighter 
images. This is especially attractive in thecase of two 
wafer tubes in cascade because the overall thickness 
of about 3 cm still provides for a very compact device. 
Film and  Camera 
The prototype uses an off-the-shelf Polaroid CU-5 
close-up camera and ASA 3000 instant processing 
film. Clearly there are other alternatives, especially if 
one increases the output brightness. Improvements 
are possible in  such areas as the proper matching of 
phosphor output wave length and f i lm sensitivity, 
optimal choice of film characteristics, and pho- 
tometer equipped miniature camera. In this 
regard, it is worthwhile to point out that MCP image 
intensifiers can also be switched on and off 
electronically. The intensifier can be switched "off" 
by applying a negative bias to the MCP input relative 
to the photocathode, thereby preventing the photo- 
electrons from entering the MCP. Such elec- 
tronically-gated operation is available, and can be 
used to eliminate the mechanical shutter of the 
camera. 
Safety  
As demonstrated with a Geiger-counter survey of 
the prototype Lixiscope, with proper design the 
radiation exposure to the radiologist can be made 
insignificantly small, i.e. not above background level. 
However, because the Lixiscope is compact, portable, 
and easy to use, it can also be easily overused on a 
subject. Therefore, it is extremely important to 
establish safe operating guidelines. It may also be 
helpful to install digital timers, both interval and 
integral (accumulative), which are triggered by the 
switch that unshields the radioactive source or turns 
on the X-ray tube. In this manner, not only are 
exposure records kept, but the timers may also serve 
as a psychological deterrent against overuse. 
Another aspect unique to the geometry of the Lixi- 
scope is the short distance between the "point" 
source and the detector. Because of this short 
distance, the dose rate to the object increases quickly 
(i.e. I/+) as it is moved from the detector toward the 
source. For example, for a 50-mCi '251 source, while 
the dose rate at 5 cm from the source is about 0.3 
mR/sec, it can reach almost 20  mR/sec a few mm 
from the source. Therefore, it is desirable to place a 
mechanical stop in  front of the source to establish a 
minimum distance beyond which the object cannot 
travel. At a minimum distance of 2 cm, for the same 
56-mCi 1251 source, the maximum dose rate is now 
about 2 mR/sec. 
Photocathode 
In the prototype, the Lanex Regular X-ray phosphor 
is coupled to an S-25 photocathode simply because 
these two components were readily available. S-25 is 
desirable for night vision because of its broad 
sensitivity extending into the infrared region. It is not 
especially efficient in  the 550 nm and ultra-violet 
emission region of the Lanex screen, nor for most of 
the X-ray and gamma-ray scintillators. A proper 
choice of photocathode, such as S-20, would improve 
both the detection efficiency and the signal-to-noise 
ratio. 
Decay Time of Output Phosphor 
Because the Lixiscope is primarily a fluoroscopic 
device and the integration time of the eye is about 0.2 
sec, it is advantageous to have an output phosphor 
with long decay time to improve the visual image 
quality. Of course the decay time should not be in- 
creased at the expense of output-phosphor eff iciency, 
nor should it be so long that it interferes with the 
observation of the dynamic motion of interest. 
STATE-OF-THE-ART IMPROVEMENTS 
Gain and  Gain Distribution 
The most important difference between the Lixi- 
scope and conventional X-ray fluoroscopy using 
diode intensifiers is that of electron gain. In conven- 
tional diode intensifiers, the photoelectron image, 
resulting from the conversion of the original X-ray 
image into a visible-light image which then impinges 
on the photocathode, is converted back to an 
intensified visible-light image by the acceleration of 
the photoelectrons onto an output phosphor-either 
with or without minification. In this approach, the 
number of photoelectrons remains constant; only 
their kinetic energy is greatly increased by the 
accelerating potential. In placing a MCP between the 
photocathode and the output phosphor, the number 
of photoelectrons is first multiplied, and then their 
kinetic energy is increased by an accelerating 
potential to the output phosphor. In the prototype Lixi- 
scope, using an inverter night-vision intensifier tube 
loaned by the Night Vision Laboratories, the electron 
gain of the MCP (L/D=40) is about 104. AS mentioned 
earlier, wafer tubes with the same L/D MCP usually 
have lower gain because of ion-feedback problems. 
Perhaps a little explanation about ion-feedback is in  
order. 
In an MCP with straight microchannels, as the 
electron gain is increased by increasing the applied 
potential between input and output, a certain point is 
reached where the electron cloud near the output end 
of the microchannels can cause ionization of the 
residual gas in the tube. The gas ions, travelling in the 
opposite direction (ion-feedback), may strike the 
photocathode or the channel wall near the input end. 
In either case, if an ion liberates an electron, another 
electron-multiplication cascade can be initiated 
following the original event. Such ion-feedback 
pulses increase noise, decrease tube lifetime, and 
cause runaway oscillations. However, ion-feedback 
can be eliminated to a large extent by using two or 
more MCP's having slanted microchannels in  series 
in  a "chevron" or "2" configuration, or, more 
recently, by using a MCP with curved microchannels. 
Either way, the ions are prevented from reaching the 
input end of the microchannels near the photo- 
cathode. Now the feedback pulses can no longer 
achieve the same gain as the true events. In addition, 
with the elimination of ion-feedback, it becomes 
possible to greatly increase the achievable gain of 
MCP's. 
However, when the gain of a curved MCP or 
chevron MCP's is pushed to 1060r 107 range, another 
phenomenon, charge saturation, occurs. That is, for 
microchannels of a given diameter and resistivity 
with single-electron inputs, a stage is reached where 
the 106 or 107 electrons near the output end, within 
the pulse duration of about a nsec, significantly de- 
crease the electric field at the output end such that no 
more multiplication is possible. At this stage, all input 
electrons will achieve essentially the same gain, and 
gain saturation results. 
Prior to gain saturation, such as i n  the normal 
operation of the nightvision MCP intensifier of our 
prototype, there is a large range or distribution of 
gains for single-electron inputs. Although one speaks 
of an average gain of, say 104, the distribution in gain 
is actually very wide and exponential in  shape. Such 
large fluctuations in  gain for pulses within a single 
microchannel, compounded with the fluctuations 
among microchannels, can give rise to contrast 
degradation and poor signal-to-noise ratios. Using a 
curved MCP or chevron MCP's in  the gain-saturated 
mode, not only is the average gain increased by 
several orders of magnitude thus resulting in  brighter 
images, but the gain distribution becomes narrow 
and peaked in shape. Such peaked gain distributions 
significantly reduce the gain variance i n  a single 
microchannel as well as among microchannels, and 
consequently improve the image quality. Further- 
more, the high gain of 106 to 107, together with the 
saturated gain distribution, make it easy to operate 
the MCP in the pulse-counting mode. This is the mode 
of operation which GSFC intends to use for X-ray and 
gamma-ray astronomy. 
It should be pointed out that MCP characteristics 
such as ion feedback, gain distribution, gain satura- 
tion, and pulse counting of single-electron inputs are 
well known and have been studied by.many 
investigators. 
For the investigation of possible use of the Lixi- 
scope idea in  X-ray and gamma-ray astronomy, GSFC 
has obtained, once again through the courtesy of the 
U.S. Army Night Vision Laboratories, an intensifier 
tube fabricated by Varo Electron Devices which 
contains an experimental curved MCP provided by 
Galileo Electron Optics Corp. Figure 1 shows the 
pulse-height, or gain, distribution of this experimen- 
tal tube for single-electron inputs. The average gain 
PULSE HEIGHT 
Figure 1. Pulse height (gain) distribution of  the 
experimental curved-MCP intensifier tube wi th  
single-electron inputs. 
for single electrons is 1 x 106 in this case, with a full- 
width at half-maximum spread of less than 50%. 
With this experimental tube, and using a thin 
(about 60 pm) evaporated Csl scintillator, we have 
found that it is possible to achieve simultaneous 
imaging and single-photon counting of 1251 and *41Am 
X-rays. Using a thick (0.6 cm) Csl(TI) crystal scin- 
tillator and a variety of gamma-ray sources having 
energies from 30  keV to about 1 MeV, our results 
indicate coarse energy resolution as well. These are 
indeed the characteristics looked for in X-ray and 
gamma-ray astronomy. On the other hand, it is 
important to note that once simultaneous imaging 
and single-photon counting is achieved, we have also 
reached far below the quantum limit of fluoroscopy, 
whatever that limit may be. 
X- Way Gamma- Way Scintilla%oas 
If one can pulse count each absorbed X-ray or 
gamma-ray photon in the scintillator, it is clear that 
the limit of information retrieval has been reached. 
Further increase in information content can only be 
achieved by improving the detection efficiency of the 
scintillator. In this regard, one is faced with the 
conflicting requirements of high quantum detection 
efficiency which demands a thick scintillator, and 
high spatial resolution with low lateral light spread 
which demands a thin scintillator. Activated Csl is an 
attractive choice for several reasons. First, it is more 
efficient than rare-earth phosphors at higher X-ray 
energies. Secondly, it has a fast decay time of about a 
psec which is ideally suited for pulse-counting 
circuitry. Thirdly, there are commercial capabilities in 
depositing, or growing, activated Csl such that it has 
light-guiding-properties in the longitudinal direction, 
with minimum spread in the lateral direction. 
Collimators 
The prototype Lixiscope uses a "point" radioactive 
source. For the purpose of imaging extended or 
spatially distributed sources, such as those 
encountered in radioisotope-intake studies, focusing 
or parallel collimators can be used in front of the 
scintillator. Alternatively, a pin hole, or multiple pin 
holes in conjunction with deconvolution instrumen- 
tation, can also be used to image extended sources. 
As is well known, collimators can also be used to 
reject scattered radiation. 
Portable X-Ray Tubes 
Nature provides only a limited choice of radioactive 
sources with the desired energy spectra, lifetimes, 
and specific activities. To be truly versatile, it is 
desirable to have an X-ray tube with continuously 
variable energy and intensity. The high gain of the 
MCP intensifiers makes it possible to use very low 
power. Furthermore, the X-ray tube can be operated 
in the pulsed mode with pulse rates of say, 20 to 30 
per sec. Using these criteria, it is within the realm of 
present technology to design and fabricate a min- 
iaturized, fully portable, battery-operated, re- 
chargeable X-ray tube. Such an X-ray tube would 
extend the usefulness of the Lixiscope to much wider 
ranges of industrial and medical applications. 
D. A COMPARlSON OF "$HE LIXBSCOPE WITH OTHER 
X-RAY IMAGING SYSTEMS 
Fearghus 0' Foghludha, Ph. D 
Department of Radiology 
Duke University 
The purpose of this paper is t o  review some 
basic imaging matters that are vitally important in  
determining the clinical potential of the 
Lixiscope. 
1. Nature of Objects Examined 
The objects so far examined with the Lixiscope 
share one or all of the following characteristics: 
(a) high contrast, 
(b) small thickness, and 
(c) small area. 
It is the possession of these attributes that has made 
it possible (and so convenient) to examine them with 
the Lixiscope in its present form, that is to say, with a 
screen of small area coupled to a low-energy nuclide 
source of modest activity. 
Though objects simultaneously having all three 
properties do occasionally turn up in  normal 
radiological practice, it is very much more common to 
meet subjects having only two or one or even none of 
these characteristics. Therefore, each of the above 
properties should be looked at to see how the Lix- 
iscope and its radiation source must be modified to 
deal with more typical subjects. It is easiest to handle 
(a) and (b) together, since the contrast and thickness 
taken in  combination largely determine the kind of 
radiation source that must be used. 
2. Contrast and Thickness 
In the human body substances such as bone, 
muscle, fat and air must be dealt with. Some of them 
(muscle and fat) have about the same density in 
g/cm3, some of them (air, muscle and fat) have about 
the same atomic number and all of themJ-iave about 
the same number of electrons per gram (see Table 1). 
Unfortunately, only if the tissues differ appreciably 
in at least one property-as bone and muscle do in 
atomic number or as air and bone do in g/cm3-is 
separation of their images on the receptor possible. 
Even then, differences do not show up well, that is to 
say the contrast is poor, unless the photon energy is 
low. To get optimum radiation contrast, then, one 
needs to use the lowest practicable photon energy. 
The use of low photon energies to accentuate 
contrast unfortunately carries a heavy and often 
unacceptable dose penalty. This is because the 
penetration of low-energy X-rays, though satisfac- 
torily different in different tissues, is small in  all of 
them, and a great deal of radiation must therefore 
impinge on the entrance surface of the patient if one 
is to get enough at the exit surface to actuate the 
radiation receptor (film, fluorescent screen, inten- 
sifier, etc.). From the point of view of reducing dose, 
the highest possible photon energy should be used, 
whereas contrast calls for the reverse. So in practice, 
some sort of compromise must be struck. 
Table 1 
3 . 0 0 x 1 0 2 3  
muscle 1 .OO 
In view of the many sites at which radiographs are 
required and the tremendous variability among 
individual patients, it is difficult to make anything but 
the crudest generalization about the optimum 
operating point. For the sole purpose of discussing 
the Lixiscope, we may assume that a suitable energy 
is somewhere in the region of 35 to 60 keV; this 
corresponds with tube voltages of roughly 70 to 120 
kV when X-rays are used.* 
3. Source Energy 
If the Lixiscope is to be operated with a radio- 
nuclide source it is first necessary to find a nuclide 
whose principal emission is somewhere in  the above 
energy region. A quick search reveals some ten or 
twelve potential sources, but closer examination 
shows that several of the candidates selected on an 
energy basis are unsuitable on other grounds. Some 
of them, for example, emit gamma rays and/or 
characteristic X-rays that lie at undesirable energies, 
in  addition to the principal radiation that would make 
them useful for Lixiscope work. In some, such as Tm 
170, there is an intense Bremsstrahlung component 
generated by accompanying beta emission; some 
have inadequate half-life; some, such as gaseous Xe 
133, are in an unsuitable physical form, and so forth. 
Considerations such as these further limit the 
practical possibilities. 
*The photon spectrum emitted by 8 tube working at e.g. 100 kV 
contains very few photons with an energy of 100 keV. These are 
accompanied by a vast number with considerably lower energies, 
so that the average energy is only l/2. or less, of the maximum 
possible value. 
4. Geometry 
To the difficulties of finding sources with suitable 
energy and half-life must be added even more severe 
restraints arising from the geometrical requirements 
of image formation. The most notable of these is that 
the source of radiation, for reasons to be explained in 
a moment, should be as far from the radiation 
receptor as possible, while the object to be 
radiographed should be as close as possible to it; that 
is to say, the source-receptor distance should be 
much larger than the object-receptor distance. In the 
case of thin objects such as human jaws and small 
animals, the requirement of relatively large source- 
receptor distance can be met'easily enough; but in the 
more usual case of the human torso, it may be 
nec.essary to station the source at a meter or so from 
the receptor. This requires that very large source 
strengths be available if an image is to be formed in 
a reasonable time. 
The reasons why the source-receptor/patient- 
receptor distance ratio should be large are to reduce 
image unsharpness, to reduce magnification and 
distortion, and to increase the effective penetration of 
the radiation through the patient: 
(a) Unsharpness: To produce a perfectly sharp 
image by shadow-casting (and radiography 
must rely on such a process because X-rays are 
not usefully refracted or reflected, and so cannot 
use image-forming elements of the optical type) 
it is necessary to use a point source of radiation. 
A practical source, whether it is the anode of 
an X-ray machine or a radionuclide, unfor- 
tunately has a finite size. Now each point on the 
surface of a finite source may be considered to 
anode anode 
A left view B right view 
cast its own image of the object, and the final 
image seen on the receptor is a composite of all 
the images cast by the multitude of points mak- 
ing up the finite source. In Figure 1 (a), for 
example, the left margin of the source images 
one edge of an object at A, whereas the right 
side of the source images the same edge at a 
point B slightly displaced from the first (Figure 
1 (b) ). The existence of this partially-illuminated 
or penumbral region between A and 6 means 
that the edge of the object is undesirably blurred 
(Figure 1 (c)). 
Figure 2 shows that the penumbral region 
(and the blurring) gets smaller as the source 
moves away from the receptor, assuming that 
the object-receptor distance is unaltered. For a 
given source size, then, it is always advan- 
tageous to back the source off from the surface 
of the patient until, when the source is far 
enough away, its dimensions as far as penum- 
bra formation is concerned are effectively zero 
and the ideal point-source condition is realized. 
(b) Magnification and Distortion: Because, as just 
seen, the radiographic image is really a shadow, 
the image is always bigger than the object, and 
the receptor must therefore be larger than the 
anatomical area that one wants to observe. This 
severely limits the usefulness of a small-area 
detector such as the present Lixiscope. The only 
way to overcome this limitation (unless sequen- 
tial scanning is used, as described in Section 5) 
is to make the Lixiscope screen at least as large 
as the anatomy." 
*but see Section 6 
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This requirement is least crippling when the 
source-receptor/patient-receptor distance ratio 
is maximized-a step we also wish to take for 
reasons given i n  the discussion of 
unsharpness-because the magnification 
diminishes as the distance ratio increases, fall- 
ing to unity when the ratio is infinite (Figure 3). 
The presence of magnification introduces 
another distressing complication; the patient 
is never as thin as the object shown in Figures 
1 (a) and (b), so the parts of him closest t o  the 
source are magnified more than the parts 
closest t o  the receptor (Figure 4(a)). This 
differential magnification leads t o  a potentially 
confusing distortion of the image. Again, 
however, this effect wi l l  be reduced'by backing 
the source away from the patient's skin (Figure 
4(b)). 
(c) Effective Penetration: A third reason for using 
relatively big source-receptor distances, even 
though they demand large source activities, is 
that the effective penetration of the photons is 
thereby increased. This comes about because 
the relative importance of one of the two photon 
attenuation processes is diminished at large 
distances. 
The attenuation mechanisms at work in  any 
radiographic procedure are (a) photon removal 
through photoelectric absorption or through 
scattering encounters that deflect photons out 
of the useful beam and (bbinverse-square fall- 
off or geometrical attenuation. The latter arises 
because the source is a point that emits its 
photons in  straight lines equally in  all directions; 
a given batch of photons therefore has to spread 
itself over an ever-increasing area as the point 
of observation recedes from the source. The net 
result is that the photon flux, expressed in  
photons/cmZ, depends inversely on the square 
of the distance from the source; this (b)-type 
inverse-square dilution occurs simultaneously 
with any (a)-type absorption or scattering 
processes and its effect is always to reduce the 
effective photon penetration below the value 
that would be observed if only (a)-type processes 
occurred. 
It turns out that the undesirable effects of 
geometrical dilution are reduced (as were un- 
sharpness, magnification and distortion) by us- 
ing the largest possible value of the source/ob- 
ject distance ratio. In Figure 5(a), for example, 
the inverse-square law dictates that not more 
than 25 units of radiation can emerge from the 
underside of the patient for every hundred units 
put in at the top even if there were no absorption 
at all. In Figure 5(b) on the other hand, where the 
source-receptor distance has been increased, 
keeping the patient-receptor distance constant, 
the inverse-square reduction is less severe and 
the maximum possible emergent amount 
(assuming (b)-type attenuation only) is 83 units 
for every 100 units entering at the top. 
The accompanying (a)-type processes will of 
course reduce the emergent intensities in both 
Figure 5(a) and Figure 5(b) by an additional large 
factor that is however roughly the same in  both 
cases. This means that the emerging intensities 
wil l  still be in  the approximate ratio calculated 
using the inverse-squark law alone, even 
though the absolute value of each intensity is 
greatly reduced by (a)-type processes (in Figure 
5, the (a)-type reduction is taken as 0.1). If 
matters are adjusted so that the exit(rather than 
the entrance) intensity is the same in both sases 
and is just adequate for Lixiscope viewing, the 
examination can be made with far less entrance 
dose to the patient using the set-up of Figure 
5(b) than using the arrangement of Figure 5(a). 
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5. Source Strengths 
For all these reasons, it is highly desirable to ex- 
amine typical subjects at very much greater source- 
receptor distances than it is possible or necessary to 
use in certain kinds of dental or small-animal study. 
Very rough calculations, based on the figures Drs. Yin 
and Seltzer have given for the 1-1 25 sources thatthey 
have found usable at short distances, indicate that 
source activities of some 2 or 3 Ci (curies) will be 
necessary at working distances of 100 cm or so. 
Quite apart from the initial and frequent renewal 
expenses, the considerable hazard, and the difficulty 
of obtaining possession licenses for activities of this 
order, another problem is encountered with most 
available nuclide sources. The volume of a source, 
other things being equal, depends on the product of 
the mass number and the half-life, divided by the 
physical density of the source material. It also 
depends on the decay scheme (which essentially tells 
the number of desired photons produced in  one 
disintegration) and on whether or not the source can 
the activity. When these additional considerations 
are brought to bear, it emerges that only one or two 
commonly-available sources have any real hope of 
filling the bill; they are 1-1 25 and Am-241. Unfor- 
tunately, the energy of 1-1 25 is rather too low for 
objects of appreciable thickness. Am-241, wi th its 
higher energy, at first sight looks quite promising but 
the theoretical maximum specific activity is about 3.3 
curies per gram. This means that the diameter of a 
carrier-free source with an activity of 2 or 3 curies is a 
few mm, which is very much greater than the focal- 
spot size in  a typical X-ray tube. No doubt there are 
other nuclides that could be used* but the point is that 
the choice is very limited. 
For this reason, work on nuclide-Lixiscope com- 
binations should be somewhat de-emphasized, ex- 
cept in applications where portability is the prime 
requirement and/or the objects happen to be suitable 
for short-distance low-activity work; the notion 
should be discarded that nuclide sources must 
be made carrier-f ree, that is, on whether all of it is "See "Some Remarks on X-ray Source Characteristics and on 
Detection Efficiencies of Prototype Lixiscopes,"Dr. Stephen M. radioactive or whether it includes inactive material Seltzer, Center for Radiation Research, National Bureau of 
that adds unwanted volume without contributing to Standards (p. 26). 
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forever be an essential part of the Lixiscope just 
because they played an important part in its original 
development. Once free of the nuclide emphasis, the 
Lixiscope may evolve as a new and very advan- 
tageous version of just one link (the standard image 
intensifier) in the imaging chain and not as a replace- 
ment for all links simultaneously. If this is done and 
attention is given to modifying the "back end" of the 
present instrument so as to give it some of the 
desirable characteristics mentioned below, a very 
rapid development should result. 
The key is to switch from gamma-ray to X-ray 
sources. With such sources, the vastly greater photon 
output is adequate for work at the large distances 
needed for good image quality and higher effective 
penetration. The effective photon energy can be 
readily changed to suit the object under investigation, 
the source diameter can be made small enough for 
good detail, and the constant hazard encountered 
with nuclide sources can be eliminated at will simply 
by switching the machine off. Last but by no means 
least, licensing becomes a very much simpler 
process. Use of an X-ray source reduces portability, 
but the problem is not insoluble since portable 
generating equipment of field-emission and other 
types is commercially available. 
If one then ceases to worry about the source and 
concentrates on receptor development, the first 
problem that needs to be tackled is that of image area. 
that may not be detected with a small-screen receptor 
unless the screen is properly positioned at the first try 
or unless many exposuresare made, thereby building 
up a large image from a mosaic of smaller ones. 
With existing Lixiscopes, a scanner to make the 
required mosaic could be built, as shown in Figure 
6(a). In this figure, a large beam of X-rays covers the 
total anatomy that is potentially involved. At the exit 
side of the patient, a lead screen is placed to shield the 
observer from the instantaneously unused part of the 
beam; the Lixiscope exit face must also be screened 
with lead glass, of course. 
With this apparatus, an arbitrarily large area could 
be examined, given enough time, but examinations 
involving dynamic processes over such a large area 
are clearly ruled out; besides, the dose is increased 
over the minimum necessary with a large-screen 
device in the same ratio as the total observing area 
bears to the area of the Lixiscope. This dose difficulty 
can be eliminated by placing the patient between two 
shields and linking them with the Lixiscope and with 
the radiation source so that they all move as one unit 
during the scan (Figure 6(b)). However, the time- 
penalty still remains." 
6. Gamma Camera Applications 
'One of the few fields where the small area of the 
present Lixiscope, though disadvantageous, is not 
entirely crippling, is in  the examination or self- 
luminous gamma-sources. Examples are implanted 
radioactive needles (cesium 137, radium, iridium 
192, gold 198, tantalum, etc.) and ingested or injected 
sources such as iodine 131 or technetium 99". 
In such cases, one can make use of the pinhole 
camera principle, whereby the source "projects" an 
image of itself onto the Lixiscope through a very small 
hole in  a plate otherwise opaque to the emitted 
radiation (Figure 7). This scheme is widely used in 
certain of the gamma cameras so familiar in  nuclear 
medicine departments, though the receptor in those 
cases works on a somewhat different principle. '-By 
suitably choosing the distances d, and dL, it is possi- 
ble to produce an image that is diminished (or alter- 
natively magnified) to any extent desired, and can 
easily be made small enough to fit on the screen of the 
present Lixiscope. 
This approach was tried.at Duke, with the help of 
Dr. J. K Goodrich*' by mounting a tungsten shield 
containing a biconical hole of 1 mm diameter in  front 
*An interesting point about the dual-shield scanner is that the 
volume of tissue instantaneously irradiated is quite small and the 
disturbing effects of scattered radiation at the receptor are greatly 
reduced, possibly eliminating the need for the anti-scatter grids 
normally used in radiography. 
**Formerly Director, Division of Nuclear Medicine. Duke University 
Medical Center, now at Radiology Associates of Erie, Erie, Pa. 
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of the Lixiscope and photographing the output screen 
with an oscilloscope camera. (See Figure 8.) With this 
apparatus, which had provision for varying the 
pinhole-Lixiscope distance so as to change the 
magnification continuously, we  were able to  pro- 
duce images of a 100  mCi Am 241 disc source. With 
approximately the same Te 99" activity, we could 
photograph liquid-source containers at reasonable 
resolution in geometries that would be conveniently 
usable in thyroid function studies, but the observation 
times were unacceptably long. With Ir 192 in the form 
of implantable "seeds", the images were of much 
poorer quality, most probably because pinhole edge- 
penetration effects are appreciable at this higher 
energy (-0.4 MeV). With radium needles (-1 MeV 
average energy), no more than a reasonable indica- 
tion was gained of the presence and layout of 
sources, and the pinhole design wil l  have to be 
modified-and the screen sensitivity greatly 
increased-if the Lixiscope approach is to have any 
great utility in this energy region.   his energy- 
limitation is not a special characteristic of the Lix- 
iscope, however, and the drawback is shared with 
other gamma cameras; so also is the flaw that the 
Lixiscope sees only the sources, whether they be 
concentrated or diffuse, and not the inactive ("cold") 
anatomy in  which they are situated. 
These experiments demonstrate the great potential 
of the Lixiscope as a compact and inexpensive gamma 
camera, usable in both industrial and medical 
applications. For routine medical use, however, im- 
(b) 
Figure 6 
provements in the present model are necessary. One 
is to increase the area, since too much minification is 
at present needed, and another is the substitution of a 
much more efficient detector for the existing input 
screen. A thin crystal of sodium iodide, for example, 
would greatly enhance the sensitivity. This aspect of 
Lixiscope development should be pursued with vigor, 
as the possibility of a hand-held gamma camera is a 
very attractive one. 
It is even conceivable that two such cameras, 
viewing a nuclide-filled organ or region, would 
provide a degree of on-line stereoscopic vision that 
might be extremely useful in  areas such as nuclear 
cardiology. In this connection, it is worth remarking 
that the inverting stage which seems to be responsi- 
ble for the lower gain of some existing Lixiscopes, 
should be retained in gamma-camera applications 
where it would rectify the automatic image inversion 
produced by operation of the pinhole-camera princi- 
ple (see Figure 7); visual observation without 
the additional inverting stage would be quite 
confusing. 
7. Future Developments 
A pressing problem that wil l  remain when large- 
area Lixiscopes become available is that there is no 
contrast amplification, because of the nature of the 
fluorescence mechanism; this serious drawback is 
shared with existing image intensifiers. Unless some 
contrast g a i ~  can be introduced (possibly by 
photographic or electronic means), the utility of the 
image 
kB 
gamma source 
Figure 7 
device will suffer in  examination of low-contrast 
objects. However, it appears that the multipliers in 
the microchannel plate can be addressed individually, 
at least in principle. If this is so, then contrast 
manipulation (including edge enhancement as in the 
present Xeroradiography system) becomes possible 
and would repay study. 
A further interesting possibility arises. If, when 
individual addressing becomes possible, some kind of 
energy discrimination were also introduced, then one 
would have a large-area detector with both spatial 
and energy resolution. This could be applied to the 
ever-present radiological problem of scatter suppres- 
sion if a source of monoenergetic radiation were also 
available, since the scattered radiation that degrades 
the image could then be discriminated against on the 
basis of its reduced energy. For reasons already 
discussed, gamma-ray sources are unsuitable 
(although they are essentially monoenergetic), but 
Duke has gone some way in developing a single- 
energy X-ray source in the form of a rhodium anode 
tube, and we are now working on other fluorescent 
anodesfrom which intense monoenergetic radiations 
of different energies are emitted. A combination of 
these tubes with an energy-selective Lixiscope would 
be a powerful tool in radiography, permitting scatter 
suppression with essentially no loss of primary 
image-bearing radiation, thereby decreasing the re- 
quired patient dose. In the nuclear medicine field, 
energy discrimination would not only reduce 
background (as in  the standard gamma camera) but 
would permit simultaneous observation of more than 
one nuclide, possibly with digital manipulation of 
several images simultaneously. 
8. Conclusions . 
The limited opportunity Duke had to work with the 
Lixiscope has led to the following conclusions: 
1. Operation of the device with a nuclide source, 
while profitable in  certain limited applications, 
is unlikely to be useful in the more standard 
radiological procedures. Greater effort should 
therefore be devoted to combining the Lixiscope 
with an X-ray source to provide a convenient, 
inexpensive and portable alternative to conven- 
tional image intensification systems. 
2. High priority should be given to the development 
of much larger viewing screens. 
3. The Lixiscope has great potential in nuclear 
medicine as a complement to the gamma 
camera. 
"Complement" is indeed the key word. It is quite 
unlikely that the Lixiscope will ever completely 
supplant more conventional radiographic and 
Figure 8 fluoroscopic equipment, but it wi l l  undoubtedly 
complement these techniques in certain situations, realizable in the field of nuclear medicine and wil l  
where its use wil l  give greater convenience in  bulk become apparent in radiographic and fluoroscopic 
and portability and, very probably, wil l  save expense; applications as large-area screens and miniaturized 
this is particularly true and almost immediately X-ray supplies are developed. 
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Ill. PRELIMINARY EVALUATION OF POTENTIAL 
APPLICATIONS OF THE LlXlSCOPE 
A. ORTHOPEDICS 
OVERVIEW 
Dr. Harry C. Prsse, Jr. 
Head of the Department of Radiology 
Howard University 
Howard University was given the opportunity to see 
the Lixiscope about six months ago. It was very 
exciting from the outset because most of the 
fluoroscopic images observed to date have been in 
large machines, while the Lixiscope is small and can 
be taken around the room for observation. Based on 
these limited evaluations, there are some limitations, 
and there are some advantages. Both are presented 
here. 
The Howard University evaluation was basically 
related to observations of the hand; although one 
could observe the foot. The source that Howard 
University had was not penetrating enough to 
evaluate other extremities. This is one of the major 
limitations. However, it is understood that there are 
features being investigated which wil l  allowobserva- 
tion of the extremities. There are some very excellent 
opportunities that the Lixiscope would offer a physi- 
cian if he was in  the emergency room. It may 
eliminate the possibility of long waits for many 
patients, particularly those with hand injuries. The 
physician could walk by 10 patients and say, "This 
one can go home, this one to the X-ray," because the 
patient has a fracture or some other pathology that 
can be picked up by a quick observation. The Lixiscope 
wil l  be helpful in this regard. 
years, which had five teams, I used to look at 
anywhere from six to seven games. The Lixiscope 
would have been helpful on many occasions. 
There is a certain amount of expertise that is 
necessary to evaluate or look at the image that is 
coming off of the fluoroscopic Lixiscope. Today a 
radiologist is used for evaluation and it is very easy 
and simple for the physician. The problem seems to 
be that if you have to train someone that has this 
Lixiscope observation expertise, then what is the 
possibility of using the Lixiscope since the radiologist 
is already there, seeing the part and examining the 
part? For instance, if you had 1,000 patients, and the 
physician could examine the part clinically and make 
a diagnosis, there would be no additional information 
added by the Lixiscope. Thus, this would be a major 
disadvantage to him. 
So Howard University is,excited about the Lixiscope 
and was pleased to look at it, but 'it must be realized 
that there are some advantages and some disadvan- 
tages. In the following discussion, both the 
limitations and advantages wil l  be presented. Six or 
eight months more of additional evaluation should 
produce a far better idea of the things that can be 
done with the Lixiscope. Its use in  areasthat have not 
even been thought about at this time are envisioned. 
For example, laryngeal fluoroscopy could be per- 
. . 
The other potential application that is interesting is formed very quickly-and easily. 
the possibility of its use at sports events. As the team Detailed results of the Ho'ward University evalua- 
doctor for the Silver Spring Boys Club for about six tion are given in  the following paragraphs. 
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Figure 2. Photograph of Patient's Hand and Wrist Figure 3. Close-Up of Patient's Finger 
Figure 3 is a photograph of much greater detail. In 
this picture, one can see the thumb to  the side, the 
wrist, the fifth finger, the little finger, and the joint 
space clearly. The "contical margin" can be followed 
to a black line, a denser black line, and then another 
black line. The fracture of the bone can be seen. Some 
evidences of new bone, or callous, can be seen which 
indicate healing of the fracture. This fracture is about 
a month old, or maybe olderthan that, andthe patient 
has no complaints at this time of pain; but there is still 
some swelling. 
The Polaroid image in Figure 4 accompanied the 
initial clinical evaluation of this patient's fracture. The 
base of the bone is off of the picture, but the beginning 
of contical margin can be seen. In this picture, one 
must reverse the images so that things that were 
white before are now black, and the white line which 
can be seen was the black line on the fracture. The 
callous, the indication of healing, can be seen and the 
fracture is evident. 
This is very gross, and to an untrained eye, probably 
doesn't mean a great deal, but it must be realized that 
the resolution of the Lixiscope is probably on the order 
of five times better than the Polaroid picture. The 
radiograph is another magnitude greater than the Figure 4. Polaroid Photograph of Patient's 
Lixiscope. with Fracture 
Figure 5 shows the hands of another patient. This is appearance of a definite fracture. But certainly, this 
an even m5ie subtle finding. In this picture some patient deserves the benefit of further follow-up and 
abnormality can be seen at the base of the tip of the of a standard radiograph and treatment. What this 
finger. The so-called "ungal tuff" of the finger is bears out is that if the Lixiscope is going to be used as 
Figure 5. Photograph of Patient's Hand Showing Figure 7. Polaroid Photograph of a Bone with 
Abnormality Posdble Fracture Line 
a screening device, it is effective. A least this patient 
wasn't sent home from the emergency room without 
further therapy. From this, it looks like the specifieity 
of the Lixiscope is probably going to be pretty good. 
Figure 8 is a photograph of an individual who had a 
soft tissue injury to his hand. He had a laceration or a 
cut, which had been stitched. He was sene to the 
Radiology Department to make sure there was no 
involvement with the bone or evidence of a fracture. 
Under the Lixiscope, it was observed that he had an 
irregularity. In the picture, a very, very subtle 
evidence of a projection can be seen along with a little 
white line and then the suggestion of some abnor- 
mality in  the cortex. Clinically, i twas believed that the 
chances of a fracture in this area were pretty slim, 
because the injury to the hand was the actual lacera- 
tion. It didn't show on the X-ray, but it was believed 
that he may have had an old fracture because of the 
abnormality. 
Figure 9 shows a close-up of the same area, and as 
suggested, some time in  the past he had some sort of 
an injury. The Lixiscope was actually able to pick up 
that little area of bone on the examination. 
Figure 10 is a picture of that bone, and it 
corresponds to some injury he had in the past. On 
questioning the patient, he admitted that he had 
boxed as a younger individual and probably broke his 
finger. It was such a small injury that he never had 
any treatment, and the injury healed up. 
This small number of cases and the small amount 
of experience Howard's Radiology Department had 
with the Lixiscope certainly justifies further evalua- 
tion as well as some clinical trials. 
Figure 8. Photograph of Soft Tissue injury to Hand 
Figure 9. Close-Up sf Soft Tissue leajury 
The advantages of the Lixiscope are its portability 
and its size. It can't weigh more than 40 pounds. 
Furthermore, the fact that it can be used in  remote 
areas and even in easily accessible areas where there 
is a need of time and movement of patients makes it 
advantageous. Certainly, it has no more radiation 
hazards than a standard X-ray. 
Its disadvantages at this point in ti,me are its small 
size and its lack of ability to study larde areas. There is 
Figure 10. Polaroid Photograph sf Old Cortical currently some work being done to alleviate these 
leajury problems. 
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B. DENTAL RESEARCH 
PRELIMINARY OBSERVATIONS AND PROJECTIONS 
Dr. Richard L. Webber 
National Institute of Dental Research 
Although there was a desire to emphasize clinical prototype. Hence, the remainder of this paper con- 
applications for the Lixiscope, this report is limited to cerns pertinent observations applicable to the Lix- 
preliminary observations and projections for two iscope considered within this rather loosely defined 
reasons: conceptual framework. 
1 ) Objective clinical evaluation requires formal 
testing, which involves a research protocol. Any 
protocol involving human subjects at potential 
risk requires appropriate clearances and 
reviews, which take substantial amountsof lead 
time. This is particularly true in an organization 
as large as the National Institutes of Health 
(NIH). In the case of the Lixiscope. a prototype 
has not been in  existence long enough to get 
such a project initiated, much less reviewed. 
2) A prototype suitable for clinical application in 
dentistry has specific requirements and en- 
vironmental restrictions over and above those 
associated with the orthopedic applications 
described by the previous speakers. 
The design of the Lixiscope at this stage i n  its 
development is not precisely determined. About all 
that can be said is that it involves three distinct 
considerations: 
1) a small self-contained source of  ionizing 
radiation, 
2) a high-speed photon detector capable of produc- 
ing an on-line image derived from a 
microchannel plate image intensifier, and 
3) a suitable geometric relationship which de- 
termines the coupling between these t w o  
Exposure Geometry 
By placing the source of radiation i n  the mouth and 
the imaging device outside, it is possible to 
significantly reduce the amount of radiation dose to 
the patient as compared with the conventional dental 
radiographic technique as shown in  Figure 1. It 
should be noted that conventional radiographs are 
produced from film packets situated inside the mouth. 
The x-ray source must emit a beam sufficiently larger 
than the film to assure that a portion of the film is not 
missed in the process of aiming. As a result, a sub- 
stantial portion of the head is subjected to radiation 
extending beyond the film plane, which contributes to 
patient dose and image degradation due to radiation 
scatter from deeper structures. 
Contrast this geometry with that shown in Figure 2 
w h ~ c h  corresponds to that made possible by the 
Lixiscope. The intraoral collimated source is rigidly 
coupled in such a way, that it is impossible for the 
beam to miss the detector. Hence, the beam can be 
made small without risk of "cone-cutting" the image. 
Unnecessary exposure is further reduced by having 
the x-rays directed from inside the mouth to the 
outside, because the only tissues irradiated are those 
of diagnostic interest plus the soft tissues of the lips 
or cheek. Figure 3 is a plot of the theoretical dose 
components. 
These conceptual ingredients are yet to be in- CONVENTIONAL 
tegrated into a prototype suitable for clinical applica- 
tion in dentistry and thus no device exists which can 
be tested for the potential applications currently 
being considered at the National lnstitute of Dental 
Research (NIDR). Given that no Lixiscope currently SO 
exists which meets the needs of a clinical research 
protocol yet to be completed, one might conclude that 
little is known about the potential applicability of the 
Lixiscope jn dentistry. Fortunately this is not entirely 
true, because the three conceptual ingredients cited 
above have been independently under investigation 
by NIDR scientists for some time. Therefore, it is 
possible to consider conceptual limitations on basic 
design requirements common to the Lixiscope in the Figure 1. Schematic Diagram of  Conventional 
absence of a clinical experience with a suitable Dental Radiographic Geometry 
PROPOSED ALTERNATIVE Another geometrical advantage of the Lixiscope 
when compared with the status quo is the fact that it 
functions as a true fluoroscopic device. This is to say, 
that it can be manipulated on-line to permit multiple 
lNTRA ''A' views to be sequentially observed to yield an in- 
IMAGE 
OLLlMATED tegrated three-dimensional conceptualization of the 
TRANSDUCER structure being imaged. The dental significance of this multiple-view capability provided by the Lix- 
iscope is illustrated by the effects of a change in 
source angulations shown in Figures 4 and 5 respec- 
tively (reproduced with the permission of Dr. K. 
Thunthy, Louisiana State University, School of Den- 
tistry). The radiograph shown in Figure 4 indicates - 
interproximal bone between the second bicuspid and 
first molar extending all the way up tothe point where 
Figure 2. Schematic Diagram of Alternative the dental enamel of the crowns joins the cementum 
Geometry Made Possible by an lntraoral Source of 
Radiation 
Key: 
i; n - lntraoral 
--- Conventional 
Figure 4. Angled Projection of Periapical 
Structures Showing Interproximal Bone Between 
the Bicuspid and Molar 
0 
10 20 30 40 50 60 70 80 90 100 
ENERGY (keV) 
Figure 3. lntegra! Dose per Photon Reaching the 
Detector Expressed as a Function of Energy for 
Conventional and lntraoral Source Models 
advantage expressed as a function of x-ray photon 
energy computed from a water phantom using a 
simple geometric model designed to compare these 
two configurations.' It can be seen that at no level of 
energy does the estimated integral dose per photon 
reaching the film plane for the intraoral source ex- 
ceed that computed for the conventional source 
geometry. Even when a liberal allowance is made for 
the acknowledged limitations of the model, it is 
intuitively obvious that exposure efficiency is greater Figure 5. Same Tissues as Shown in Figure 4. 
when the source is located intraorally, because radia- Altered Projection Geometry Reveals Large 
tion extending beyond the film plane does not con- Periodontal Lesion Between the Bicuspid and 
tribute to patient dose. Molar 
covering the surface of the respedtive roots of these 
teeth. Figure 5 shows the same teeth projected from a 
slightly different source position. The bone in the 
interproximal region of interest is now seen to b e  
missing next to the molar all the way up to the apexof 
the root. Thus, it is easy to see how this huge 
periodontal lesion could be missed by limiting con- 
sideration to a single x-ray projection as conven- 
tionally practiced. The potential diagnostic advantage 
afforded by the exposure geometry of the Lixiscope 
under these conditions is self-evident. 
Radiation Source 
In addition to the obvious advantages of simplicity, 
self-containment, and small size afforded by the use 
of an isotope as an x-ray source, the monoenergetic 
nature of the energy spectra produced by suitable 
isotopes has interesting implications for fluoroscopic 
applications. For example, l 2 5 I  used in the prototype 
Lixiscope described previously has line spectra 
narrowly clustered around 29 keV(see Figure 6). Also 
shown is a typical aluminum-filtered spectrum 
produced by a conventional dental x-ray machine. 
The relative maximum spectral output is ap- 
proximately at the same energy as that produced by 
lZ5l, but the conventional source produces a much 
broader spectrum ranging from zero to 60 kVp or 
more. This basic difference in energy distribution has 
a significant effect on the potential maximum amount 
of information available depending on the nature of 
the diagnostic task to be accomplished. 
The exact nature of this relationship was explored 
by C. 0. Henrikson2, who used a hydroxyapatite- 
water phantom to model the caries detection task in 
teeth having a variety of equivalent thicknesses. By 
taking into account the linear attenuation character- 
istics of the tissues he was able to determine the 
minimum radiation dose as a function of x-ray energy 
required to reliably detect a one mm3 lesion assuming 
an ideal radiation detector. 
The results of this exercise are shown in Figure 7. It 
can be seen that the optimum energy, i.e. the energy 
requiring the lowest dose for reliable caries detection, 
depends on the thickness of hydroxyapatite to be 
penetrated. Of particular interest is the fact that 
energies around 30  keV appear optimum for the 
detection of small lesions in the 2 mm hydroxyapatite 
model. This suggests that for relatively thin calcified 
tissues 1251 has a nearly ideal spectrum. On the other 
hand, thicker tissues require significantly higher 
energies to efficiently yield diagnostic information at 
the same level of reliability. Translated in terms of the 
Lixiscope, this means that 1251 wil l  require significant 
doses to produce satisfactory images of calcified 
structure with equivalent hydroxyapatite thickness 
greater than 3 mm. Of even more importance is the 
fact thatthis limitation is of a fundamental nature that 
cannot be changed by manipulation of other elements 
in  the system. Clearly, efficient use of an isotope such 
as 1251 requires that the Lixiscope be limited to a 
relatively narrow range of diagnostic applications. 
Conventual 90 kVp 
Aluminum Filtered 
X-Ray Source 
'a/) 
Monoenergetic 
Peaks Produced 
by 1251 
0 10 20 30 40 50 60 70 80 90 100 
ENERGY (keV) 
Figure 6. Relative X-ray Energy Spectra of a 
Conventional Source and '251 
(1) 7mm model 
12) 5mm model 
(3) 3mm model 
(4) 2mm model 
10 20 30 40 50 60 70 80 
Energy, keV 
Figure 7. Dose as a Function of Energy for Various 
Hydroxyapatite Models (Courtesy of 6.0. 
Henrikson) 
Perhaps the most novel aspect of the prototype 
Lixiscope involves the use of a high-gain micro= 
channel plate image intensifier as an x-ray detector. 
Figure 8 shows schematically the basic elements of 
this device. x-ray photons containing information of 
diagnostic interest cause a fluorescent screen to emit 
luminous energy which in  turn activates a proximity- 
coupled photocathode. The resulting electrons are 
accelerated at high potential through a coherent 
array of hollow glass tubes fused into a disc-shaped 
structure called a microchannel plate (MCP). Each 
tube acts like a miniature photomultiplier, so that 
each electron entering the plate creates an avalanche 
of electrons, which are detected at the output by a 
proximity-coupled phosphor screen to create a visible 
image. 
Rational selection of MCP specifications demands 
an assessment of clinical requirements. Quantum- 
limited photomultiplying devices are intrinsically 
noisy, so that there is a definite need to determine 
how much information is necessary to perform tasks 
of diagnostic interest. The research in  this area is only 
beginning to yield answers which confirm the task- 
dependent nature of image quality. The over-all 
efficiency of information transfer is also influenced by 
the choice of detector. This effect is illustrated by 
comparing the information capacity per dose pro- 
duced bytwo typical x-ray imaging-systems as shown 
in Table 1. It can be seen that there is slightly more 
than a three-to-one ratio in  information capacity 
between screen and no-screen systems, whereas the 
ratio between respective doses is more than an order 
of magnitude. This means that the higher speed 
system is more than five times as efficient in  
transfering information. The use of high-speed 
screens with the Lixiscope makes possible a substan- 
tial increase in  efficiency for a variety of potential 
applications in dentistry. The anticipated compromise 
in image quality is illustrated in  Figure 9 (courtesy of 
Dr. J. Gibbs, Department of Radiology, Vanderbilt 
University). The only difference between the dental 
radiographs shown is that the one at the top was 
Photon Electron 
Photon To Electron Electron To Photon 
Gain Conversion Gain  conversion 
Photocathode Output 
Phosphor 
Table 1. WeBatioslship Between lnfosmatiorai 
Capacity and Dose 
PA E 
PA Screens 
Information Capacity (Bits) 168,000 52,000 
Dose (mR) 5 0  3 
Capacity/Dose (BitsFmR) 3,360 17,200 
produced conventionally, whereas the bottom 
radiograph was produced with an intensifying screen 
inside the intraoral film packet. 
For many routine' diagnostic tasks in dentistry, it 
appears obvious that the image quality of the bottom 
radiograph would bp adequate. This conclusion is 
substantiated bv the, observation that a reduction in 
computed signal-to-noise power ratio of ap- 
proximately 30 percent failed to significantly in- 
fluence the detectability of incipient interproximal 
lesions from bite-wing radiographs when tested 
parametrically with 140 degrees of freedom.3 In this 
case, image degradation was produced by prefogging 
Figure 8. Schematic Diagram o f  MCP image Figure 9. Comparison of  Conventional (Top) and 
intensifier Used in the kixiscope Screen-film System (Bottom) 
no-screen film with unmodulated x-ray exposure as 
exemplified in Figure 90. Of course factors other than 
source geometry, spectral characteristics, and detec- 
tor speed influence image quality obtainable from 
Lixiscope, and these too must be considered in order 
to characterize unequivocally its diagnostic potential 
in dentistry. At least some of these have been 
addressed by Dr. Yin in  a recent paper presented 
under the auspices of the Society of Photo Optical 
Instrumentation Engineers.4 
While the image appears to  be an encourgaging 
example of what has already been accomplished 
with the Lixiscope, its future in dentistry wi l l  un- 
doubtedly depend on how well it performs in  actual 
clinical situations, particularly when used as a 
fluoroscope. Hopefully the interest generated by its 
development and expressed in this conference wil l  
be sufficiently sustained t o  adequately test its 
potential in  the clinical practice of dentistry. 
Figure 90. Effect of Unrnodulated Radiation on 3. Webber, R. L and L Stark, Investigative Radiol. 7, 6, 
Posterior Bitewing Radiograph, Darker Region on (1 972). 
Right has 30% Reduction in Estimated Signal-to- 4. Yin, L, J. Trombka, S. Seltzer, R. L Webber, M. Farr, 
Noise Power Ratio and J. Rennie, NASA Technical Memorandum 79634. 
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DOSlMETRlG CONSIDERATIONS IN DENTAL APPLlCATiONS 
John 6. Goble, Sc.M. 
National Institute of Health 
Department of Health, Education, and Welfare 
The use of intraoral sealed sources in conjunction 
with the micro-channel plate technology may provide 
increased diagnostic information with decreased 
radiation dose compared to conventional dental 
radiographic techniques. These reductions in radia- 
tion dose are a result of several factors, some specific 
to the prototype NIH device, and others more 
generally applicable. These advantages include: 
1 ) Reduced depth dose 
2) Reduced volume of irradiated tissue 
3) Real-time operator feedback 
In addition to these specific advantages, the in- 
tegration of the Lixiscope into dental procedures may 
reduce the total number of normal radiographic ex- 
posures required. 
Reduced Depth Dose 
Due to the spectral distribution of energies pro- 
duced by bremsstrahlung in the target of an X-ray 
machine, some of the photons emitted from the tube 
head approach the applied accelerating potential. In 
general, dental radiographic exposures are made at 
80-90 kVp. Since these high energy photons 
penetrate both bone and soft tissue quite readily, they 
provide little radiographic contrast yet penetrate 
deeply into the irradiated tissue. 
In using isotopic sources of photons, the problem of 
high energy contamination of the beam iseliminated. 
Since the photons are emitted at discrete energies, 
beam energy may be optimized for a particular 
application by selection of the appropriate 
radionuclide. 
Reduced Volume of Irradiated Tissue 
Acollimated intraoral source provides many advan- 
tages with respect to volume of irradiated tissue 
(whether the image receptor is a microchannel plate 
device or not). In the normal dental techniques, at 
least two factors contribute to the large volume of 
tissue irradiated. 
Since there is considerable uncertainty in the 
positioning of the film within the patient's mouth, the 
beam must be wide enough to ensure that the struc- 
tures of interest will be imaged. In a more narrowly 
defined beam, the incidence of retakes will be much 
higher. This geometry produces irradiation of tissues 
that are not of interest to the dentist, and which are 
outside of the image receptor. By rigidly coupling the 
image receptor to the source, and collimating the 
beam size to the diameter of the input phosphor, 
needless irradiation of tissue is reduced. The effects 
of depth dose and of limited beam geometry are 
compared for the NIH prototype device and an 80 kVp 
unit commonly used for endodontic procedures. 
Doses are normalized to 1.0 rad at 1 cm on the beam 
centerline (Figures 1 and 2). 
A second major advantage stems from the fact that 
radiation dose to the tissue beyond the film is 
eliminated. The volume of tissue irradiated during the 
normal radiographic exposure includes not only those 
structures between the source and the film, but those 
tissues in the "shadow" of the film as well. In the 
intraoral geometry, only the tissues of interest are 
irradiated. 
Real-time Operator Feedback 
The real-time imaging technique permits the den- 
tist to examine the structures of interest at an angle 
that optimizes their visibility. In the normal 
radiograph, patient movement, poor film plqcement, 
improper techniques, and many other factors may 
contribute to the necessity of a retake. By receiving 
real-time feedback, thedentist optimizes the informa- 
tion available from the minimum number of ex- 
posures. 
Specific Design Considerations 
in the NIH Prototype Device 
With the practical nature of this conference in 
mind, a few comments on design considerations in 
DEPTH IN TISSUE 
Figure 1. Effects of Depth Dose using 80 kVp 
X-rays 
design goals of the device include: 
1) Maximum Exposure Rate: 1.0 R/min 
2) Maximum Leakage Radiation: .1 mR/hr at 1 
meter 
3) Beam Collimation: Rate at edge of input 
phosphor to be less than 10% of center-line rate 
4) Shielding of Operator: Less than .1 mR/hr to 
eyes 
Although these considerations are quite conser- 
vative and are specific to the NIH device, they are at 
least a starting point in making the Lixiscope a prac- 
tical clinical tool. Many of the advantagesseen in this 
1 .O 5.0 10.0 design follow from the intraoral geometry and from 
DEPTH IN TISSUE the rigid coupling of source and image receptor. 
Figure 2. Effects of Depth Dose using 1-1 25 Similar improvements in radiation dosimetry might 
well be made in  devices not using the microchannel Lixiscope Source 
plate technology. Because of the unique advantages 
the NIH device are probably appropriate. Although no of this particular configuration, however, it seems 
specific standards for the device exist, the NIH likely that the Lixiscope can provide adequate 
Prototype was designed to meet or exceed re- diagnostic information for a great many tasks with 
quirements for diagnostic type units. Some specific decreased radiation dose to the patient. 
C. MAXILLO-FACIAL DIAGNOSIS 
Dr. Allan 8%. Weiskin 
Universiw of Connecticut Health Center 
School of Medicine 
The use of fluoroscopy in dental practice is uncom- 
mon for many reasons. Dynamic studies, for which 
fluoroscopy is best suited, are not often required. The 
cost of currently available devices is extremely high, 
the units are large, and imagedetail is poor compared 
to film. While the Lixiscope in its present form has 
made substantial progress toward resolving the 
problems of the cost and size, image quality is still a 
problem. 
As illustrated in Figure 1, the structures which are 
dealt with in dentistry are extremely small. The 
periodontal ligament which forms the attachment of 
tooth to bone is only a fraction of a millimeter wide. A 
change in the size of this space is often one of the 
most significant indications of incipient but treatable 
disease of the tooth, its supporting bone, or its attach- 
ment. A doubling of the size of the ligament space 
may represent less than one quarter of a millimeter, 
and therefore, images must be capable of resolving 
these extremely small changes to be of primary 
diagnostic value. The periodontal ligament space was 
selected as an example of the dimensional re- 
quirements of X-ray diagnosis in dentistry because it 
is similar in size to a variety of normal and 
pathological structures which are of importance. 
The image in Figure 1 was produced with Kodak 
ultraspeed film. Its resolving power is illustrated by 
endodontically, that is vital tissue has been 
removed and replaced with a sterile dressing. The 
attachment at the apex of the root is thickened 
(arrow) indicating residual disease. 
use of a test pattern shown in Figure 2. The films are 
quite small (Figure 3) because most dental structures 
are paired and would superimpose upon each other if 
both the radiation source and the image receptor 
were outside of the oral cavity. In current practice, it is 
the image receptor which is inserted into the oral 
cavity, although this projection geometry can be 
reversed by using either rod anode X-ray tubes or 
isotopic sources such as those described by Dr. 
Webber and others (see reference). 
In addition to the high resolution radiographs 
already seen, other types of diagnostic images are 
used in dentistry. A thick section tomoclram (pan- 
Figure Il (a) .  This radiograph represents a view of oramic) is shown in Figure 4. This image reveals a 
the roots of molar and premolar teeth. The disadvantage of static images, namely artifact 
attachment of tooth t o  bone (the periodontal associated with movement. The illustration reveals 
ligament) is indicated by the arrows. the image of a bony fracture with all of the 
Figure 3. A coin was placed on top of a dental fiim 
to  illustrate its relative size. Cour;lesy of the 
Eastman Kodak Co. 
Figure 2(a). This image of a lead test target was 
made on Kodak ultraspeed fi lm using 90 kVpX-rays 
and standard processing conditions. With 
magnification, one can resolve 2 8  line pairs per 
millimeter. 
Figure 46. The defect indicated by the arrow 
represents motion a ~ i f a c t .  
radiographic characteristics that one expects to see in 
a classical case of trauma. In reality, however, the 
fracture is an artifact which resultedfrom the sudden 
movement of a patient during the exposure (1 6 sec.). 
The dynamic nature of Lixiscope images would cer- 
tainly reduce the probability of confusing this type of 
artifgct with genuine trauma. 
Figure 5 shows a thin section tomogram through 
the articulation between the mandible and the cranial 
base. In this, as in other instances, it is found that thin 
section tomography, which is a comparatively high 
dose procedure, is necessary because dnatomical 
constraints do not permit one to view thislarea ade- 
Figure 2($). A baa pattern used for assessing] focal quately with conventional imaging , systems. 
spot size was also imaged on Kodak ultraspeed film However, the reversed geometry which could be used 
and confirms the high resolution observed with the with the Lixiscope might eliminate the need for 
diverging lines. tomographic examinations in many patients. The 
collimating devices which ultimately provide the 
same dose-sparing affect achieved by reversing the 
geometry. As long as the radiation field is no larger 
than the size of the image receptor and shielding is 
provided to prevent penetration beyond the plane of 
the film, then substantial savings can be attained. 
Under these conditions the dose-sparing advantaas 
of reversed geometry may be less dramatic. 
It is important to remember that there are problems 
other than the small size of the objects which are 
dealt with and the exposure requirements of any 
particular system. For example, the reduction of a 
three-dimensional object to a two-dimensional image 
can result in significant information loss. Small 
changes in angulation can have dramatic effects on 
the information content of a resulting radiograph and 
Figure 5. This tomogram represents a thin section in many instances it is impossible to predetermine the 
(approximately 1 mm) using a linear tomographic optimal projection geometry without some type of 
system and a 40° angle. system for previewing the final image. In spite of its 
Lixiscope would also provide a less expensive sub- 
stitute for the tomographic equipment which is now 
required. 
The evaluation of any imaging device must ul- 
timately include a consideration of the radiation 
economy of the image detector. There can be a 
considerable dose-sparing affect by reversing the 
geometry of image production in  some dental 
procedures. This reversal, compared to more com- 
monly used geometries, reduces the total amount of 
tissue which is exposed in the radiation field. 
However, as shown in Fiaure 6. one can use 
Figure 6. A large number of collimating devices are 
available for use with dental films. This  articular 
relatively poor resolution, the Lixiscope might provide 
a simple and inexpensive device for previewing pro- 
jection geometry prior to the production of an image 
on film. Such a procedure may be practical because of 
the Lixiscope's high gain. Obviously, the Lixiscope 
could be used either with isotopic sources (see 
reference), or with an extended rod anode X-ray 
source shown in Figure 7. Rod anode x-ray sources 
are commercially available and have been used for a 
variety of diagnostic procedures in  the maxillofacial 
region. The configuration and size of the x-ray source 
make it possible to insert the device into the oral 
cavity so that any imaging device can be placed in an 
extra-oral position. Combined use of the Lixiscope as 
a previewing device with high resolution hard copy 
films should reduce the total number of films and 
improve their quality. 
instrument is made of stainless steel and restricts Figure 7. This illustrates the tube of a Siemens 
the X-ray field to the size of the film. A metallic Status-X device. X-rays are emitted from the end of 
backing behind the film preventspenetration of the the tube which is small enough to be inserted into 
X-ray beam beyond the image plane. the oral cavity. Courtesy of the Siemens Gorp. 
A further advantage of extended rod anode x-ray 
sources and reversed geometry is the possibility of 
using extremely small focal spots and magnificatiqn 
as a means for improving image quality. In order to 
assess the impact of source size and other factors on 
image quality with the Lixiscope, we conducted 
several preliminary studies. Resolution was 
measured with a variety of test targets using bar and 
star type patterns. The data is summarized in Figure 
8. Studies were conducted with x-ray sources having 
different spectra, including narrow energy bonds 
produced with rare earth filters and conventional 
sources. Isotope sources of iodine and gadolinium 
were also used. The sources varied in size from 
approximately six tenths of a millimeter to more than 
one millimeter and source to object distance was 
varied from a few inches to several feet. Under these 
conditions, images were produced on two Lixiscopes 
with different gain characteristics. Both instruments 
had variable gain controls and each was used in 
extreme high gain and low gain settings. The basic 
conclusion of our studies was that the resolution of 
these Lixiscopes was limited by several factors to 
approximately four line pairs per millimeter. First, the 
phosphor which converts radiation to light in these 
prototypes was relatively coarse. Second, since both 
instruments produced higher quality images in their 
low gain modes and the low gain instrument produced 
an image with greater resolution than its high gain- 
counterpart, we presume that internal problems such 
as ion feedback near the surface of the microchannel 
plate or poor contact between screen and fiber optic 
might limit the resolution of the Lixiscope to levels 
which are belowthe requirements of many diagnostic 
procedures. It is also important to note that resolution 
measurements were made by recording images on 
Polaroid films which required relatively long ex: 
posure times. The resolution data which we obtained 
LlXlSCOPE RESOLUTION 
RESOLUTION (L.P./mm) 
MCP SOURCE Max. G. Min. 6. 
H.G. 70  kVp x-ray 4.0-5.0 5.0 
H.G. 36 kVp x-ray 2.2-4.0 
H.G. '53Gd 3.5 3.0-4.0 
L.G. 36 kVp x-ray 5.5 
L.G. 70  kVp x-ray 4-5.5 
L.G. 1251 4-7 
Figure 8. Resolution measurements made under 
different conditions with different Lixiscopes are 
summarized. Resolution of four or five line pairs per 
included the integration which is achieved by the film 
over a period of time. This integration is considerably 
greater than that which can be achieved by human 
eye and our measurements may be deceptively high. 
Our conclusions should also be qualified by the 
observation that there were consistent differences 
between measurements made with each test target 
and it was not possible to determine which of the test 
targets provided the most appropriate type of 
measurement. 
Thus far, the Lixiscope evaluation has been in the 
context of a primary diagnostic device. It is important 
to recognize, however, that there are many situations 
in which an imaging system is used in conjunction 
with, or as support for, other procedures. A procedure 
has been described in which the Lixiscope was used 
to obtain working information during endodontic 
procedures. Similar uses of the Lixiscope might be 
made at other anatomical sites during other types of 
clinical procedures. Prime examples include ar- 
thrography and sialography. In these procedures, 
contrast agents are used to fill joint cavities or the 
ductal structures of salivary glands. These are usually 
dynamic studies in which it is important to establish 
that the contrast agent is deposited at the correct 
anatomical site and flows according to some predict- 
able pattern based on our knowledge of normal 
anatomy and physiological function. Figure 9 shows a 
Lixiscope image of a needle placed in the knee joint of 
a rabbit. The size of the needle and the size of the joint 
are similar to what we would encounter in a human 
temporomandibular joint. The ability to manipulate 
the Lixiscope around the joint proved to be an enor- 
mous advantage in correctly placing the needle. On 
the other hand, the Lixiscope had the disadvantage of 
making the production of a hard copy record extreme- 
ly difficult. Because exposure times were relatively 
millimeter may not be achievable by direct viewkg Figure 9. Shows a needle inserted into the knee 
and may represent a gain resulting from integration joint of a rabbit. All of the structures are sharply 
accomplished by the film. defined including the bevel on the needle. 
long, it was not uncommon to produce images such 
as that seen in Figure 10 with a large blur fringe that 
obscured detail. By comparison, Figures 11 and 12 
show temporomandibular joint arthrograms pho- 
tographed on Polaroid film from a video screen 
after recording on a magnetic disc and a similar image 
obtained on film by a tomographic procedure. Figure 
13 shows a plain film of the same site which was 
necessarily taken at an oblique angle. Although the 
image quality is relatively high, the projection 
geometry required to view this site compromises the 
utility of the examination. Direct lateral viewing 
which could be achieved with an intraoral source and 
a Lixiscope would have distinct advantages. 
In conclusion, the very brief experience with the 
Lixiscope established several points. First, in its 
present configuration, the Lixiscope appears to have 
value primarily as a previewing device for conven- 
tional radiography or as a working instrument to be 
used in association with or in support of other 
procedures. Second, the Lixiscope, in its existing 
configuration does not have sufficient resolution to 
function as a primary diagnostic tool for most dental 
needs. Finally, it is necessary to emphasiie that we 
have examined primitive models of the Lixiscope and 
the technology for substantially improved devices 
already exists. Sufficient inforpation has been 
developed to support the desirability of constructing 
second and third generation Lixiscopes with larger 
and more uniform fields, with advanced design, 
microchannel plates, and with improved phosphors. 
Reference 
Henrikson, C. 0 . :  "Iodine 125 as a Radiation Source for 
Odontological Roetgenology," Acta Radiologica Suppl., 
269. 1967. 
magnetic discs may be significantly poorer than 
those wisuallmed directly on a Lixiscope screen. 
Figure 72. The bixisiope and the video disc do not 
- compare in image iual i ty with thin section 
tonnograms such as that illustrated here. 
Figure 10. This image shows the result of motion Figure 13. Greater sharpness and detaii Is obtained 
introduced as sr result of long exposure times. A in plain fiBms such as this a~hrogram in which the 
blur fringe can be seen along the edge o f  the needle lower compadment of the temporomandibular 
and less clearly, at the edge of bone. joint has been filled with opaque material. 
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There are a couple of things about pediatric 
radiology that indicate a particularly apt application 
for a low-dose portable X-ray device such as the 
Lixiscope. 
The actual experience that any of us has had with 
the Lixiscope in approaching clinical problems and 
applying it to phantoms has been relatively limited. 
There is a certain risk in discussing clinical 
applications in  a simplisticor facile fashion because it 
is not certain what the Lixiscope can or should be in 
its final configuration. There is another problem 
when one leaves small dental structure application 
for larger structures of medical radiographic applica- 
tion, in that the configuration of the Lixiscope as it is 
now is fairly constraining. Part of the problem is that 
the device has been given a name and a patent 
number and one tends to think of it in  its current 
configuration; that is, an isotope source rigidly 
coupled to a high-gain image intensifier that 
measures one inch in diameter. 
As various medical applications are analyzed, it 
becomes apparent that a more flexible design ap- 
proach is needed. The device is a series of com- 
ponents which includes a source of radiation and an 
input phosphor with some characteristic that wil l  
complement the radiation incident upon it. The image 
intensifier, a competent high-gain intensifier, is real- 
ly the device that makes this instrument different 
from existing systems. The use of a radioisotope 
source for diagnostic imaging is not unique. It has 
been used for field pack radiographic units in  the past 
with high energy isotope sources. 
From the medical standpoint, bigger patients re- 
quire more flexibility in thinking about the design 
approach to the whole imaging system. 
However, given the present constraints on the 
instrument, it was convenient to think about using 
the Lixiscope for a tiny patient. The youngest of the 
pediatric patients are quite tiny. The application that 
was most tempting to think about was in  the neonatal 
intensive care unit for premature infants, usually 
with respiratory distress. Sometimes these tiny little 
@ babies are only 800 or 1,000 grams or 1,500 grams. 
In the Lixiscope evaluation, an experimental rabbit 
was used which was much larger than a very tiny 
premature infant. 
The other important consideration in  pedratrics 
relates to radiation exposure. This brings up a whole 
new problem area regarding radiation effects, and 
that is not the intent of this paper. It is known, at least 
as a generalization, that radiation is not good for us, 
and it should be avoided if possible. There is some 
indication that the riskof late tumor development may 
be enhanced i n  infants that are born to mothers who 
have had abdominal radiation, pelvimetry, while the 
baby was in the uterus. That is still controversial, and 
the data vary, but there is strong concern about what 
is being done to these babies. Even once they are 
beyond the in utero stage, there is a general accept- 
ance that during the sensitive phases of develop- 
ment, whether in utero or in  the first months or even 
years of life, the theoretical risk to the patient is 
greater than in  an adult organism. Thus, the lowdose 
aspects of this device are appealing. 
The potential use of the Lixiscope for the Infant 
intensive care unit is very interesting. The neonatal 
intensive care unit at the University of Connecticut 
Health Center has some 15 or 18 bassinets. There are 
250 or 300 transfers each year of distressed infants 
from surrounding community hospitals which do not 
have sophisticated maintenance facilities into the 
University of Connecticut Health Center. The actual 
transport mechanism, or vehicle, is affectionately 
called the "whale." It is a large bus, or superlarge van, 
that measures about 40 feet in length and is manned 
by a driver, a physician-nurse team and additional 
supporting personnel when necessary. It provides 
numerous support devices for monitoring and main- 
taining blood pressure and respiration. Some 
laboratory facilities, including blood gas deter- 
minations, are available, and it is really a fairly 
sophisticated transport vehicle. 
The object of this obviously is to get the baby from 
the referring hospital into the neonatal intensive care 
unit in as safe and as rapid a way as possible. These 
are critically ill infants who are very sensitive to 
temperature changesand changes in  ambient oxygen 
concentration, and the transfer has to be made 
relatively quickly. Actually, what happens is that the 
pediatric intern goes with a nursing team to the 
referring hospital, examines the infant to be 
transferred, and decides vvhat immediate stabiliza- 
tion must be done in  the referring hospital. Thisoften 
includes obtaining radiographs and placing various 
tubes. The infant is then put in the transport vehicle 
and brought to the Medical Center. 
There would be some advantage if part of that sta- 
bilization time could be avoided. Thus it was tempt- 
ing to think about the possible use of the Lixiscope in 
the transport vehicle so that tubes and catheters 
could be placed and some radiographic evaluations 
could be made of the infant during transport. Again, 
the Lixiscope seemed to satisfy some pediatric needs. 
It wil l  be necessary to be careful in  using this 
instrument to conform to each institution's human 
investigation guidelines. One of the concerns the 
developers of the instrument have had is what it wil l  
do to the radiation burden for the entire population. It 
is nice to think that the dosage or radiation wil l  be cut 
down by fluoroscoping the tip of a finger to see if the 
broken needle is still impacted, but it makes one a 
little bit anxious to think of legions of physicians 
running around with Lixiscopes in  their pockets, 
screening patients and doing various other 
evaluations. This could result in  a substantial in- 
crease in the total population radiation dose and is 
reminiscent of the old fluoroscope in  the shoe store 
before it went out of vogue. 
The following paragraphs describe some of the 
ideas and the direction of thinking regarding potential 
applications for the Lixiscope. The figures which are 
presented fall into three groups. First are some con- 
ventional radiographs to illustrate the type of thing 
that is presently being dealt with in  the infant or 
neonatal population: different things that happen to 
the babies, where their tubes are, what the tubes are 
for. Also presented is a series of pictures that il- 
lustrate the images that were made with the Lix- 
iscope using an experimental rabbit. Finally, in a very 
theoretical and speculative frame, some of the other 
uses appropriate for the Lixiscope or a modification of 
it are presented. 
Figure 1 is a normal chest X-ray in an infant. The 
heart is in the center and partly surrounded by a mass 
of tissue which is the thymus gland. The picture 
shows some faint markings running out to the 
periphery of the lungs which represent pulmonary 
blood vessels, and some of the airways can be seen. 
Figure 2 shows one of the problems that might be 
encountered. The heart is no longer in the center; it 
has shifted to the patient's right side, and the left lung 
is very radiolucent. What has happened is that the 
lung blew out. It was stiff because of underlying 
pulmonary disease; it required greater airway 
pressure to maintain oxygenation. It simply popped 
like a balloon and collapsed when air leaked out. The 
collection of free air within the chest markedly 
decreases the ability to oxygenate the baby. If one 
could recognize this sort of a problem, when an acute 
change in the clinical status occurs during transport, 
therapy could be given by tapping the air collection 
with a needle or tube. 
Figure 3 shows the chest tube that was placed in 
the same patient. The heart has moved back to the 
midline because the abnormal air collection was 
successfully drained. 
Figure 4 shows some other types of tubes. One is 
used in an infant who had a gastrointestinal problem, 
and it is called a hyperalimentation line. It is placed in 
a vein over the shoulder at the base of the neck, and 
inserted into the vena cava that runs into the right 
side of the heart. It is a mechanism for getting high 
caloric concentrations into an infant, but that can't 
be done well in  the tiny veins of the arms and legs 
because they wil l  clot. It is not uncommon to see one 
of these tubes, when placed blindly, directed into the 
Figure 1. Normal Chest X-Ray of an Infant 
Figure 3. Chest X-Way of  Chest Tube In an infant 
Figure 5. Endotrachael Tube Placed in  the Upper 
Trachea of  an Infant. Along wi th  the endotracheal 
Figure 4. Chest X-Ray of Other Hypes of Tubes in . 
an lnfant 
tube is an umbilical vessel monitor 
Figure 6 shows a nasogastric tube. This has a 
radiopaque strip, either lead or barium, impregnated 
within the wall of the tube. In general, these are some 
of the things that one is concerned with in the 
neonate. 
Figure 7 is the first in a series of pictures made of 
the rabbit used i n  our evaluation. Some of the Lix- 
iscope screen defects mentioned earlier appear. 
Some of the anatomic studies made on the rabbit are 
head rather than the heart. and that is not a good presented. There was interest in seeing whether an 
place to put a very high concentration solution. 
. - 
~ i ~ u r e - 5  shows an endotracheal tube which is used 
to maintain respiration. k is placed in  the upper 
trachea, and one has to know where the tip of the 
endotracheal tube is so that it is not wedged in  one of 
the two major airways, one supplying the right and 
one supplying the left lung. Obviously, if it is wedged 
in  the right one, then the left lung is not going to get 
aerated very well, so one would like to know fairly 
accurately what the position of this tube is. 
Also on the radiograph is an umbilical vessel 
catheter. It is fed in  through the stump of the umbilical 
cord into the umbilical artery, and it is advanced into 
the major artery of the body, the aorta, where it is 
used for taking blood samples. Again, the position of 
the tip is fairly critical. It should be kept away from the 
orifice of the vessels to the kidneys and some other 
major abdominal organs, and that requires knowing Figure 6. Nasogastric Tube with a Radiopaague 
where the tip is. S t ~ p  Impregnated within the Wall of the Tube 
Figure 7. image of  Interspace between Two Bony Figure 8. Diaphragm of a Rabbit 
Ve@ebrae of  the Spine of a Rabbit 
image could be made of the spine itself or the space 
between the bodies of the spine for space application. 
It's fairly crude, but one can distinguish an interspace 
between two bony vertebrae and can see some of the 
structures of the vertebral body. 
It was also decided to test the Lixiscope to see the 
diaphragm, the junction between the chest above 
containing air, and the water density abdomen below. 
One could see it, but it wasn't easy in the rabbit, as 
illustrated in  Figure 8. Interestingly, even though with 
the hard-copy image one gets a chance to integrate 
more information because it's exposed over a period 
of time, there's a certain advantage in  being able to 
move the fluoroscope over the part that you are 
looking at or having the part move under it. The 
diaphragm was clearly recognizable because it could 
be seen moving up and down and one sometimes gets 
a three-dimensional concept by being able to observe 
a structure from a variety of directions. 
Figure 9 is a chest tube placed within the esopha- 
gus. It is reasonably well-defined, and the ribs are 
again well-seen against the aerated lungs. 
After sacrificing the animal, some iodinated water 
soluble contrast material, sodium diatrozoate, was 
placed into the trachea. As shown in Figure 10 it 
produced very nice imaging. That it has to do with 
the combination of using an iodinated compound for 
contrast material and -radioiodine as a radiation Figure 9. Chest Tube Placed within the Esophagus 
source. The filled esophagus shows up as a very black of a Rabbit 
Figure 10. Sodium Diatrogonate Placed into Figure 1 1. Feeding Tube in the Esophagus 
Trachea of a Rabbit Exposed through the Neck of a Rabbit 
band. This was in the neck, and some of the bodies of 
the vertebral column in  the neck can be seen. 
Figure 1 1 shows a feeding tube that was placed in 
the esophagus and is also through the neck Once 
again the vertebral bodies can be seen and the space 
between the bony structures, the joint space, is 
detectable in the picture. 
A post-mortem angiogram was made using a nee- 
dle to place the iodinated contrast material directly in 
the heart by a blind puncture. In Figure 12, the dark 
shadow of contrast i n  the left ventricle ayd a tubular 
structure-the major artery or the aorta-coming off 
the heart can be seen. It istherefore possible to image 
these deep structures, in a 3,000 gram rabbit, par- 
ticularly if aided by the use of contrast material. 
In the following discussion some very speculative 
applications are presented. These are speculative in 
the sense that it's questionable as to how much wil l  
be added to patient care by being able to do these 
studies, and, secondly, because the equipment in its 
present configuration is not capable of performing the 
studies. 
Figure 13 is a fracture of the skull in  an infant that 
was born by a forceps delivery; it's pushed in. It is 
usually not terribly important to know about skull 
fractures unless they happen to be pressing on the 
adjacent brain tissue, and this is fairly gross. Normal- 
ly, it is hard to see the depressed fracture unless you Figure 7 2. Left Ventricle and Aorta of the Heart of 
get the patient into exactly the degree of obliquity that a Rabbit 
Figure 13. Fracture of the Skull of  an infant Figure 14. Tube Placed within the Ventricular 
System of the Brain of an Infant with 
will show it in profile, and that's difficult to do with Hvdroce~halus 
standard views. What is really needed is an infinite 
number of images or fluoroscopy while rotating the 
head. It might be possible to use the Lixiscope for 
preliminary evaluation the same way the dental lab 
patient might be screened for caries, to at least scout 
the skull if there is sufficient penetrating power with 
the instrument. 
A child with hydrocephalus, or water on the brain, 
is shown in Figure 14. Tubing has been placed 
within the ventricular system of the brain, to drain the 
excess fluid, and it is of some interest to the 
neurosurgeons, as they do this procedure, to deter- 
mine the location of the tube. 
Figure 15 shows a patient with slipped capital 
femoral epiphysis. The head of the femur has slipped 
off of its neckand it had to be stabilized by use of these 
pins. In this situation one would like to be able to see 
an infinite number of projections to be sure that one 
of the pins isn't sticking into the joint space. This 
would be difficult for the Lixiscope because the pelvis 
and hip are very thick structures requiring high 
energy for penetration. 
The simple fracture in Figure 16 looks like it is well- 
aligned when seen from the front. One might be 
inclined to say, "Well, this is a pretty good reduc- 
tion of the fracture, and all we have to  do is put it 
in a cast." However, as seen in Figure 17, which was 
taken from the side, there is marked angulation at the 
Figure 15. Patient with Slipped Capital Femoral 
Epiphysis 
.fracture site. Again, the actual geometry is important Figure '8 6. Fmnt Picture of Simple Fracture 
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Figure 18. Kidney Stone in Right Kidney 
Figure 17. Side Picture of Simple Fracture 
and may be difficult to work out using conventional 
studies. 
In Figure 18, a kidney stone is seen in the right 
kidney as an oval density. At the time of surgical 
removal of multiple renal stones, it is useful to 
radiograph the kidney during the operation to be 
certain all stones have been removed.There are ways 
of using a sterile film holder behind the kidney or 
adjacent to the kidney in the surgical wound, and 
exposing the film with a portable X-ray machine, but 
there is no theoretical reason why the entire Lix- 
iscope could not be introduced into the surgical site, 
into the peritoneum. In other words, one could gas 
sterilize the Lixiscope screen and heat sterilize the 
radiation source and then just wrap the Lixiscope up 
after it is sterile and put it into the patient during the 
surgery to image what is going on-where the stones 
are. 
Figure 19 is an operative cholangiogram. The gall 
bladder has been removed because of stones, a tube 
has been placed in  the duct that carries bile from the 
gall bladder and the liver into the bowel. One would 
like to know at the time of surgery whether all the 
stones are out or if thevare im~acted in theduct. If the 
Lixiscope were introdked inio the abdominal cavity, Figure 19. Operative Cko!angiogaam with Tube 
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it would be interesting to see if better detail imaging 
or better geometrics of imaging in this type of intra- 
operative procedure could be obtained. 
Figure 20 shows a patient who had a long periodof 
fever and had some ill-defined bone lesions. The 
figure shows the pelvis, and there is an abnormal 
lucency in the right iliac bone. 
As seen in Figure 21, there was a similar abnor- 
mality in one of the ribs, and it was decided to get 
some tissue by biopsy for diagnosis. The possibilities 
included a primary or mestastic tumor, an osteo- 
myelitis or infection that had seeded t o  the ribs, or 
some other kind of unusual abnormality. It is of 
obvious importance to have a diagnosis, and this 
requires getting a biopsy of a piece of the involved 
tissue. 
The surgeons initially went in  and did a biopsy of a 
rib which came back negative. Afollow-up radiograph 
was done on the patient and found that the wrong rib 
had been removed, an understandable error resulting 
from difficult orientation at the time of surgery. This 
raises another theoretical possibility: could the 
fluoroscopic screen of the Lixiscope be used to image 
radioisotopes that have been injected in  the patient, 
such as for conventional nuclear medicine studies? 
Can a bone-scanning agent be injected in  the patient 
at the time of surgery, to expose the bone through the 
incision and look at it with the Lixiscope to decide 
whether the abnormality has been identified as in- 
dicated by increased radioactivity? If this can be done, 
and there is no inherent reason why it cannot, this 
sort of an error might be avoided by accurately localiz- 
ing the site for bone biopsies. 
Figure 20. Picture of Pelvis 
Figure 21. Picture of Ribs with Abnormalities 
Figure 22 is a lymphangiogram, a very tedious 
study where one makes a skin incision in the foot, 
finds a tiny little lymphatic channel, half a millimeter 
in  diameter and almost transparent, and sticks a tiny 
needle into it to instill contrast material that wil l  fill up 
the lymphatic vessels and then fil l the lymph glands. 
Using this examination, one can see whether there is 
leukemia or lymphoma or other tumor invading the 
glands, or at least if there is destruction of the normal 
glandular architecture by a disease process. 
After the needle has been inserted, one is not 
always sure that contrast material is going where it 
ought to be going, that is, into the vessel, or whether it 
is just leaking into the adjacent tissues. It might be 
possible to use the Lixiscope to identify whether 
contrast material is beginning to go up the lymphatic 
channels. 
Secondly, there are some radioisotopes presently 
in  use that are useful in identifying tumor tissue or 
infected or necrotic tissue, and one can occasionally 
discover hidden foci of tumor or infection by external 
scanning. It would be interesting, at the time of 
operation for lymph node biopsy, to have injected 
some of this material sufficiently ahead of time so 
that the Lixiscope screen could be used to identify the 
most abnormal lymph nodes by determining the site 
of the greatest radioactivity. 
In summary, one can getfar afield without restraint 
on imagination. The first group of pictures showed 
what the problem is; the second group showed what 
type of images can be obtained now using a rabbit for 
evaluation purposes. In the third set of photographs, 
some very speculative applications for the Lixiscope 
were presented. There are potential benefits in the 
Lixiscope, but to a medical radiologist the concept of 
the Lixiscope should be relaxed. It does not have to 
have the specific form of the present instrument but 
might be a series of component parts that could be 
designed in different ways and exchanged in different 
ways: an isotope source for some applications, a 
conventional X-ray source for other applications, an 
input phosphor designed to meet the task at hand, 
and hard-copy image or simplyfluoroscopic real-time 
viewing depending on the specific information 
desired. 
More clinical experience will be needed with the 
Lixiscope and it wil l  be necessary to be mindful of the 
population burden of radiation that may be introduced 
with the Lixiscope. Certainly the engineering 
possibilities for the Lixiscope can be very exciting, and 
seem almost limitless. 
Figure 22. Lymphangiogram 
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It should be noted from the outset that this is a "pre- 
preliminary" report since Dr. Anthony Kidawa and Dr. 
Gerald Gorecki and I had the Lixiscope for ap- 
proximately an hour in the foot clinic at a not very 
busy time. 
However, based on this limited evaluation time, the 
use of the Lixiscope stirs the imagination and the 
possibilities for its clinical use seem endless. 
Podiatry is a very surgically-oriented speciality and 
a great deal of this surgery is done in an office. Along 
these lines, a technique of minimal incision surgery 
has developed in the last few years. It is used primari- 
ly for permanent removal of excressences, commonly 
called corns, on people's toes or between people's 
toes. Usually they are caused by small, bony 
prominences, an exostosis or a hypertrophy of a 
phalanx. It is quite simple to remove them, and cure 
the patient's problem, by making approximately a 
quarter of an inch incision, which is why it is called 
minimal incision surgery, and remove the offending, 
bony prominence. 
Figure 1 is a drawing of the toe. It has a little red nail 
on it and three phalanges in  it. On the head of the 
proximal phalanx is a very common place for an 
increase in  bony density, just enough to cause the 
patient to develop a localized pressure reaction or 
hyperkeratosis. 
However, it often does not show up well on an X-ray 
and there are limitations in the views that are taken. 
Of course, additional views can be taken, butthen the 
patient is exposed more and more to radiation. 
In the surgical procedure a quarter of an inch 
incision is made, a bone rasp is inserted, and the bony 
prominence is removed. Thus, the Podiatrist is almost 
doing the surgery blind or by feel. 
However, if the Podiatrist had a small fluoroscopic 
unit that he could quickly put over the area and take a 
look to make sure he was in the right place or that he 
had removed enough bone or had not removed too 
much bone, the procedure would be much improved. 
Every Podiqtrist would have one of these units in his 
office. 
On a slightly larger scale, the use of such a device 
on the operating room table would be an advantage. 
Figure 2 shows the metatarsal bones in a foot. Fre- 
quently, the Podiatrist does surgery on the bases of 
the metatarsals as shown in the Figure. 
Obviously, if work is done on the first or the fifth 
metatarsal, there is very little trouble in properly 
Figure 1. Drawing of  a Toe wi th  an Increase in  Figure 2. Drawing of the Metatarsal Bones in a 
Bony Density Foot 
locating these. However, on the base of the second, 
third and fourth, where the area is primarily bone, it is 
very difficult to determine whether the Podiatrisris 
operating on the correct one or not. This is especially 
true on the third or fourth, which is between all the 
others. 
Again it would be advantageous to have a quick 
fluoroscopy unit that would be sterile and could be 
used in the operating room to make sure that the 
Podiatrist is working on the right one. 
Figure 3 is a side view of the heel bones: the ankle 
bone, or the talus, and the bone in the heel, the 
calcaneus. There is a little hole in the middle called 
the sinus tarsi. 
In children who have very flat feet, a surgical 
procedure is done in which either a piece of bone or a 
piece of medical grade silastic is inserted into the 
sinus tarsi. It only takes about an inch or an inch-and- 
a-half incision. It is right underneath the skin and is 
easy to get to. But grossly it never looks the same as 
on X-ray with these abnormally shaped bones. This 
necessitates bringing in an X-ray unit, and taking a 
picture on the table to make sure i t  is in the right 
place. This wastes a half hour and the longer thechild 
is on the table and under the anesthesia, the more 
morbidity, post-operatively. 
Again, a Lixiscope could show this right i n  the 
operating room. It would tell the Podiatrist that he is in 
exactly the right place and has accomplished what he 
wanted to. 
The Lixiscope would have the same applications in 
treatment of trauma, fracture reductions, and so 
forth. If the dose is as low as claimed, then it beats a 
regular fluoroscopy unit, and it is better than doing a 
closed reduction of a fracture, X-raying it, doing 
another closed reduction because the site was 
missed the first time, and then X-raying it again 
and maybe doing it a third time. The X-ray exposure 
would be reduced considerably. 
Another application that is very desirable is the 
Figure 3. Drawing of the Side View of the Heel 
Bones 
unlimited number of views one can get with a quick 
sweep with a Lixiscope. The Lixiscope can pass 
almost 360 degrees around a small joint in a matter of 
a few seconds, something that would take a con- 
siderable number of X-ray views and still not catch 
exactly what was wanted. 
This was demonstrated very neatly in the clinic on a 
patient with an ulceration on the toe. Osteomyelitis or 
a bone infection was suspected. The bone infection 
was not detected with standard X-ray. However, the 
Lixiscope showed that right around the corner, where 
the two-plane radiograph could not show, the begin- 
ning periosteal reactions to the infection could be 
seen. Therefore, using the Lixiscope, a case of os- 
teomyelitis was detected two weeks before it showed 
up on standard radiographs. Again, another great use 
for the Lixiscope. 
The Lixiscope also magnifies. It was found that one 
of the screens magnified everything by about twice 
the size. This can also be accomplished on a regular 
X-ray. It was also found that the resolution was not as 
great as desired at times. 
For foreign body location, the value of the Lixiscope 
is obvious. Today, a number of implants in the foot are 
made of metal or silastic. To examine an implant after 
it is in, the regular or standard X-ray views are taken 
and a static or nonfunctioning view of the implant is 
made. To look at it under fluoroscopy, a rather long 
exposure is needed. 
If it could be done quickly with a low-dose Lix- 
iscope, it could be determined if the prosthesis is 
functioning properly as planned or i f  it is in the right 
place during gait. 
In the lower part of Figure 3, where the talus and 
calcaneus can be seen, two of the three joints 
between these two bones, the posterior and middle 
facets, are indicated. Occasionally, a tarsal coalition 
is found in young adults. That means that the two 
bones that should be separate are fused together. 
This causes muscle spasticity in the leg because the 
muscles are not able to function properly, leaving 
quite a painful foot. It is difficult to diagnose. 
If an X-ray view is made of the posterior aspect of 
the ankle with the right angulation, the middle and 
the posterior facets can be seen. However, it is very 
difficult to get that view properly and have it be 
meaningful. 
If the X-ray is off by two or three degrees, the joint 
space will be missed. That is a problem because in 
every individual the angulation of those facets is 
different. To get the proper view, i t  is necessary to 
expose them at least three or four times. 
If the Lixiscope could penetrate a thick part such as 
described, it would be a natural; and it would cut 
down the radiographic exposure considerably. 
Sometimes X-rays are taken with a patient's shoe 
on, since shoes can cause a great deal of pathology. 
So a device with good penetrating power is needed. It 
should be stronger than the Lixiscope is now. But, 
again, it would be a natural for that use. 
Another useful application would be in 
arthrography, or taking X-rays of joints with dye in the 
joint. The hardest part is placing the needle in the 
joint. If the joint is missed, the dye is spilled into the 
soft tissues, and nothing can be seen. An X-ray or the 
fluoroscopy unit can be used, but a device that gives a 
much lower dose and can be used rather quickly is a 
natural for this application. 
The Lixiscope, therefore, seems to have a few 
features that make it appear quite promising. It is 
really easy to use and it is fast. It is easy to over- 
expose a patient because once you start looking, you 
just keep going from joint to joint and around and 
around. It also takes a fair amount of experience to be 
able to pick up what you want to see. It is not the same 
as looking at an X-ray. Without experience the patient 
can be over-exposed. However, it does give a low 
dosage. It is excessively movable, sometimes too 
movable, and it is a bit difficult to photograph some of 
the pathology. For example, a foot was placed under 
the Lixiscope or in the Lixiscope, and the camera was 
connected. It was difficult to find what had originally 
been found because everything had been moved. To 
get a good picture, the patient's leg had to be twisted 
because the stand would not move properly. To 
alleviate this problem, the Lixiscope definitely needs 
a lot of development. 
There are also some other negative factors or 
disadvantages. For instance the resolution was found 
to be less than adequate at times, especially when 
trying to examine joint surfaces. Arthritic joint sur- 
faces don't show well. It did, however, show bony 
impingements. If the two opposing surfaces of the 
joint were no longer parallel, it could be seen, and 
when the joint was moved, the bony prominences 
could be seen impinging. Of course, this could be 
done under anv fluorosco~v unit. 
It was a little difficult used to the inverted 
image at times. The Lixiscope does not penetrate a 
thick part. It is great for toes, but unfortunately it is not 
so great for the back of the foot and for ankles. 
The Lixiscope needs a system for exposure calcula- 
tion. In its present configuration, you turn it on and 
maybe, time it; although it would be nice if it had a 
built-in timer. A little beeper like a Polaroid camera 
would be advantageous. 
Figure 4 shows a distal phalanx, the middle 
phalanx, and the interphalangeal joint space. The 
resolution is not too good. It is not as good as looking 
through the actual Lixiscope. Figure 5 again shows an 
interphalangeal joint. The break in continuity, a minor 
trauma, can be seen in this picture. 
Figufe 4. Distal Phalanx, Middle Phalanx, and 
Interphalaepgeal Joint Space 
Figure 5. Interphalangeall Joint 
Figure 6 shows the medial aspect of a metatarsal Figure 6 .  The Medial Aspect of a Metatarsal 
phalangeal joint. The patient had a very small bunion. Phailasageal Joint 
The uneven joint space was defined. Unfortunately, 
the patient moved and the desired picture was not 
obtained which appears to be another problem with 
the Lixiscope. 
Figure 7 shows a patient's finger with psoriatic 
arthritis. The little grooves which are characteristic of 
the disease are on the tip of the phalanx. The picture 
shows some bony reaction. The patient caught the 
finger, or injured it, in  a lawn mower a week before 
this was taken. 
Figure 8 is a lateral view of the distal end of the toe 
and the distal phalanx. The curve can be seen. This 
picture is one that is never seen with an X-ray. It is 
very difficult to take little pieces of film and put them 
between people's toes and shoot without having 
them move. This just illustrates one of the unique 
applications for this Lixiscope. It has a great future 
with a little bit more development. Eventually, it may 
be in every Podiatrist's office and quite a few dental 
offices. 
Figure 8. Lateral View of the Distal End of the Toe 
Figure 7. A Patient's Finger with Psoriatic Arthritis and the Distal Phalanx 
F. VETERINARY MEDICI1NE 
Lt Col. Richard Simmonds 
Uniformed Services University of the Health Sciences 
Depafiment of Laboratory Animal Medicine 
The Lixiscope was evaluated in relation to 
veterinary medicine at the Uniformed Services Uni- 
versity for about three hours. However, before Pepor- 
ting on the results of this evaluation a few words on 
fluoroscopy in veterinary medicine are in  order. It 
must be stated that there are very few clinicians in 
veterinary medicine who use fluoroscopy. 
This primarily relates to the fact that most 
veterinary medicine is done, at least in  small animal 
practice, in what is usually a fairly well-equipped 
hospital. Most veterinary practitioners have their own 
radiographic equipment handy. 
In large animal medicine, it is probably more a 
matter of economics than anything else. Most 
farmers probably wouldn't be willing to pay the fees 
necessary for on-the-farm fluoroscopy examinations. 
Veterinary clinicians in regular clinical practice do 
very few implantations of prosthetic joints and what- 
have-you which further limits their requirements for 
fluoroscopy. 
For these reasons there probably is not a great need 
in clinical veterinary medicine for a fluoroscope. 
Following its development, if the Lixiscope maintained 
its portability, and if the costs could be reduced, 
it is possible that there would be a market for it in 
clinical veterinary medicine. The market would be 
primarily with the large animal practitioner who 
would want something to take out on a farm; in 
animal sporting events such as horse and dog races, 
pet shows, horse shows; and possibly even in the 
- small animal clinic for rapid real-time examination of 
an injury. 
In academic medicine, it is a different situation. In 
research, fluoroscopy is used considerably, but it 
usually relates to cardiovascular work or research 
work to a certain extent similar to some of the 
material presented earlier about rabbits. Such use 
would include looking at catheter implantations or 
blood flow using radiopaque dyes, and frequently the 
examination is done on larger animals than the 
Lixiscope currently can penetrate. 
So,,in general, fluoroscopy is not used all that much 
in veterinary medicine. 
However, the Lixiscope was evaluated in  several 
ways using a mouse, a rat, a cat, and a dog. Even 
though the unit is very portable, it gets to be "athletic" 
with unanesthetized animals. It took six people to 
A good resolution was obtained with the bony 
structures in the smaller animals (the rat and the 
mouse) and the extremities of the cat. If there is a 
need to take a good, quickscan of the bony skeleton of 
a mouse or rat, it can be done very well with a 
Lixiscope. 
With the Lixiscope, internal organs of the smaller 
animals could be visualized by the movement of the 
organs. A Polaroid picture of that view or visual field 
wobld not show very well. The same situation applied 
to the diaphragm in smaller animals. 
The resolution of the bones in the extremities of the 
cat and dog was fairly good, as can be seen from the 
photographs which follow. The body and torso bones 
of the larger animals were not visible; the tissue could 
not be penetrated with the iodine, and too much 
penetration occurred with the dylinium. 
Figure 1 shows photographs of radiographs taken 
out of a text book, to illustrate the type of detail 
desired with bony structures. This is a radiograph. 
With fluoroscopy, you do not get this kind of detail. 
However, one can see the internal structure of the 
bones, and when compared to the Lixiograph 
photographs, it gives some idea of the difference 
between the two. 
One of the things noticed with the Lixiscope was 
that it had very poor soft tissue definition with the 
current model. If it could obtain more soft tissue 
definition as in  Figure 2, it would be helpful. 
operate the Lixiscope and the camera, hold the Figure 1. Photographs of Radiographs f r o m  Text 
animal, and get the position. Book 
Figure 2. Desired Soft  Tissue Definition 
Figure 3 is the metatersus of the cat with the 1-4 25 
source and a lanex screen. This was a two- or three- 
second exposure and the movement of the cat 
resulted in a foggy photograph. However, it is not bad 
as a clinical picture. As pointed out earlier, the 
orifices, the joint spaces, and the condyles can be 
seen fairly well. From a clinical standpoint, this 
probably would be all a practicing veterinarian would 
need to scan a cat's paw for a lesion which may have 
something to do with the bone. 
Figure 4 is the heel bone of a rat, using the os calcis 
process with the 1-1 25 source, lanex screen and a 
one-second exposure. If you had some interest in the 
skeleton of a rat, keeping in mind the degradation of 
the detail on the photograph versus the actual screen 
of a Lixiscope, it is quite applicable and quite usable. 
Figure 5 is approximately the same view using the 
wafer tube screen. Considerably better detail can be 
seen. It is a little fuzzier because a longer exposure 
was taken, there is less visual light output from this 
screen, and the animal moved. Nevertheless, it is 
fairly good detail, and if the animal was a bit more 
immobilized and the camera set up and everything 
steadier, some pretty good pictures could be obtained. 
Figure 3. Metatersus of  a Cat with 1-126 Source 
Figure 4. Heel Bone of a Rat using 8-1 25 Source 
and kanex Screen 
Figure 5. Heel Bone of a Rat using Wafer Tube 
Screen 
In conclusion, based on the evaluation, it is believed 
the Lixiscppe has a great deal of promise. Depend- 
ing upon the economics of the final product, there 
may be a place for it in  clinical veterinary medicine. 
If the cost of the Lixiscope is about $5,000, with 
anywhere from $800 to $4,000 a year for the 
isotopes, there are very few practicing veterinarians 
who are going to pay that much for one. However, if 
the price came down in development, it has a good 
future in veterinary medicine. It probably wil l  be 
limited to a great extent to rapid evaluation of bone 
fractures or abnormalities and possibly to veterinary 
dentistry. 
There is a small problem with licensure. There are 
very few veterinarians currently with isotope 
licenses. However, that would be a minor problem 
which could be easily resolved. 
It is believed that veterinarians probably will be able 
to use the Lixiscope as described here, but they will 
not be the drivers. They will ride along with somebody 
else pushing the system. 
%M. TECHNOLOGY UTILIZATION 
A, AN OVERVIEW OF THE NASA TECHNOLOGY 
blTlLlZAP!QN PROGRAM 
Mr. Louis Mogavero 
Technology Utilization Program 
National Aeronautics & Space Administration 
Washington, D. C. 
The speed with which technology is moving is an NASA has done to accelerate this transfer process 
awesome thing, and to those who are in the business is to  develop a technology utilization program. The 
of transferring technology, it is even more so. Tech- purpose of this paper is to  discuss NASA's tech- 
nology sets the pace for our entire economy and way nology utilization program. 
of life; and therefore, whatever, benefits and stimulates The problem is - how does NASA get this 
technology, benefits everyone. One of the world's technology into the warehouse; how does it extract it 
largest and most effective pacesetters of this advance from the warehouse of knowledge and get it back into 
in technology is the NASA aerospace program. The the hands of taxpayers who paid for the technology in 
purpose of this paper is to explain how NASA the first place? 
develops the technology and gets that technology into The first step to be considered is how to get people 
the warehouse of knowledge and then out of the to know that the technology exists and is available? 
warehouse and into the economy. First of all, when NASA contractors, and also NASA 
In the following paragraphs some examples of people within the NASA field centers such as the 
where the technology comes from and its uses or Goddard Space Flight Center, develop new 
spinoffs of our technology, are presented. Briefly, technology, the technology is reported and screened 
NASA's mission is to explore the Earth and its sur- for some potential commercial use. If it has potential 
roundings, conduct aeronautical research, and put the commercial use, it is then written in a one-page 
results of this Research and Development to work for dissertation called a "tech brief" (Figure 1). This is a 
the benefit of mankind. The Shuttle is a reusable one-page description of the technology in lay 
Earth-to-orbit work horse that delivers payloads to language with pictures or sketches explaining some 
orbit, eliminating costly launch vehicles. One impor- of its potential uses. Each tech brief identifies the 
tant feature is its ability to retrieve unmanned name of the innovator. For instance, if a person from 
satellites for repair or return to Earth. It is launched the Goddard Space Flight Center has developed an 
, like a rocket, and returns like an airplane. innovation, his name is included. Therefore, if you 
In aeronautics, NASA is doing research to provide have a question when you read the tech brief you can 
safer, quieter and more energy efficient aircraft call that person to get more information. 
which has less impact on the environment. Earth 
orbiting satellites provide information that offers 
enormous practical benefits to help manage the 
Earth's resources such as crop growing conditions 
and changing land uses. And finally, NASA has 
launched more than 300 spacecraft into Earth orbit 
and into deep space to gain knowledge about the past, 
the future, and perhaps man's destiny. 
In less than two decades, man has learned more 
about the Universe than in all the prior years of history. 
It is from these programs that NASA develops a vast 
reservoir of knowledge which can in turn be used to 
solve earthborn problems. The second use of this 
technology is called "spinoff". While the list of 
spinoffs is impressive, the process is far from 
automatic. Technology may move or it may not move, 
and if it does move, it moves slowly if left alone. What 
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Figure 1. Tech Brief 
About two years ago NASA developed the Tech 
Brief Journal. Previous to the Tech Brief Journal, 
each piece of NASA technology was written onone 
page and sent out as a one-page description. People 
read them and sometimes misplaced them or threw 
them away. It just wasn't a very effective way of 
retaining the information. 
The new Tech Brief Journal contains about 150 
tech briefs per journal, and is issued quarterly. This 
increases the shelf life of the technology because an 
individual can place these in his or her bookcase, and 
at the end of the year consult an index and refer back 
to the technology. It has been found, over the years, 
that people generally take about two years to actually 
get to use the technology they previously read. 
If more information is needed to support the Tech 
Brief, technical support packages are available. These 
are notes that the innovator has written about the 
technology as he developed it. Figure 2 is a plot of the 
requests for technical support packages. Last year 
over 100,000 requests for technical support 
packages were received by NASA. This is significant. 
There are about 35,000 or 37,000 people who receive 
the Tech Brief Journal; and if over 100,000 people 
requested additional information, that issome indica- 
tion that there is value in  the Tech Brief Journal. For 
every Tech Brief published, there are about three to 
four people who request support packages. 
Some examples of the uses of the Tech Brief 
Journal and also the information within the Tech 
Brief are discussed in the following paragraphs. 
The first example is the technique for providing 
special types of plastic foams. Figure 3 shows an 
assortment of Scott's reticulating foam filters used in  
the automobiles, lawnmowers, motorcycles and 
other vehicles. A Scott engineer learned about NASA 
technology from reading one of our Tech Briefs and 
later requested a technical support package. This 
technology was instrume~tal  in reducing the product 
development time. 
REQUESTS FOR TECHNICAL SUPPORT PACKAGES (TSP's) ALL YEARS 
NASA HQ KT77-3876 (1) 
9-28-77 
Figure 2. Plot of Requests for Technical Support Packages 
Figure 3. Reticulating Foam Filters 
NASA has been asked by a number of people, 
particularly the Congress, to evaluate the benefits 
and the cost benefits of the tech briefs and the Tech 
Brief Journal. Denver Research Institute looked into 
this and randomly selected names from the list of 
people who requested technical support packages 
and questioned them about their uses, asking what 
the benefits were, and asking them to evaluate quan- 
titatively the amount of dollars saved in one way or 
another. 
As shown in Figure 4, there is a reported savingsof 
$70 million dollars. When you consider that NASA 
puts $6.4 million dollars over that five-year period 
into the Tech Brief Journal program, you can see that 
there was an 1 1 to 1 return on the investment. That is 
to say, for every $1 NASA uses to publish the Tech 
Brief Journal, there was a reported $1 1 benefit to the 
user. 
TECH BRIEF PROGRAM 
Cost Benefit Analysis 
NASA HQ KT77-1678 (I  ) 
2-3-77 
Figure 4. Cost Benefits of the Tech Briefs and theTech Brief Journal 
Another method used to disseminate NASA 
technology and accelerate its use is the Industrial 
Application Centers (IACs). These are listed on the 
chart in Figure 5. The lACs provide a face-to-face 
relationship between the manufacturer and the 
technologists. The IAC's have teams (most are uni- 
versities or nonprofit organizations) that go out into 
industry, identify the industrialist who may have a 
problem, discuss the problem with the industrialist or 
the manufacturer, go back into the NASA data bank, 
search for information that may be useful to him, and 
turn the information over to the industrialist or the 
manufacturer and let him apply that technology to 
improve his product or processes or develop new 
products or new processes. 
There is a charge for the service. The charge is not 
for the research and development; but for discussing 
the problem with the industrialist, identifying the 
problem, and searching for the technology and get- 
ting the right technology to him. 
When you sit down and talk to the technologist 
face-to-face, many times a technologist is helping 
you define the problem. In act, 50 percent of the 
time the value of the face-to-face interchange of 
information helps the person with the problem to 
identify his real problem. For example, an aluminum 
casting manufacturer recently approached one of the 
Industrial Application Centers and said, "I would like 
to have some information on the temperature at 
which I should pour my aluminum. I think I am 
pouring it too hot. What temperature should I use to 
pour this aluminum?" After discussing it with the 
technologist, he quickly came to the conclusion that 
heat wasn't his problem. It was the resin he was 
using in his molds. He was using the wrong kind of 
resins. So the search was conducted for different 
kinds of resins for the kinds of molds he was using, 
not for pouring temperatures. That is an example of 
how the face-to-face interchange with the 
technologist helps identify the real problems. 
The costs for this program are underwritten in part 
by the TU program in the Federal government, by the 
fees charged to the users, and support from the 
universities. /
DEMONSTRATIONS TECHNOLOGIST 
DESIGN, BUILD 
TEST 
MANUFACTURERS NATIONAL ORGANIZATIONS 
NASA HQ KT77 2800 (1) 
5-1 1 -77 
Figure 5. NASA Industrial Applications Centers 
The data bank that these lACs have contains over a 
million technical reports that come from NASA's 
research and development programs plus an ad- 
ditional seven million reports worldwide. It is one-of 
the largest data banks in the world, and it is growing 
at the rate of 50,000 documents per month. 
Some examples of how this type of activity helped 
solve technical problems are described in the follow- 
ing paragraphs. 
In a cooperative effort between our Industrial 
Applications Center in New Mexico and Goddard 
Space Flight Center, engineers applied heat pipe 
technology from NASA's Skylab program to construct 
the Alaska pipeline. The heat pipe anchors that are 
holding up the pipeline are shown in Figure 6. The 
heat pipes stabilized the underground temperature 
which prevents the supports from moving during the 
seasonal temperature change. 
The heat pipes, called cryo-anchors, are placed in 
areas where there is an extreme change in 
temperature between summer and winter. If they 
were not there, the foundations would move, thereby 
causing ruptures in the oil pipe. 
An example on a smaller scale, one of the 
lndustrial Application Centers in California supplied 
information to a company on chlorate candles. A 
chlorate candle gives off oxygen when it burns; and 
this helped the company to develop a portable 
welding kit. These can be found in most hardware 
stores. It is portable, hand-held, and can deliver 
temperatures up to 5,000 degrees which means that 
one can weld and cut steel. 
One of our Industrial Applications Centers provided 
information which led to the development of a device 
for recovering flue heat using heat pipe technology. 
This is shown in Figure 7. The right-hand corner 
shows the heat pipe that is placed in the flue. When 
the heat goes up the flue, the heat pipes transfer the 
heat to the other end of the heat pipe. A fan motor 
Figure 7. Device for Recovering Flue Heat 
blows it back into the heating system and 
recovers it for use in the house. 
Another Industrial Application Center is Cosmic, at 
the University of Georgia (see Figure 8). This is a 
repository of NASA's software programs. In that 
repository, they have over 1,600 computer programs. 
One example of the use of one of the computer 
programs is the NASTRAN, which stands for NASA 
STRuctural ANalysis program. This is one of the 
world's most sophisticated structural analysis com- 
puter programs in the world. Cadillac used the 
program to develop its Seville model. NASTRAN cut 
the engineering time for its dynamic structural 
analysis to  a fraction of the normal time. 
NASA uses another method of transferring 
technology to the public sector (see Figure 9). 
Transferring information and technology to the public 
sector is a somewhat different problem. In the public 
sector, you can't transfer information and then step 
aside. They need solutions. Public sector people are 
just no geared as the private sector is, to  take on 
the ~esearch  and ~evelopment  and apply it, do 
the Drototv~e work, and taking it throuah to 
. . - - 
commercialization. 
What the public sector needs is a demonstration; 
that is, they would like to expalin the problem, have 
NASA look for the technology, build the hardware, 
then demonstrate that the technology can be used 
to solve their problem. At this point, NASA puts the 
hardware into the commercial marketplace, has the 
private sector bit on it, and lets the commercial 
marketplace supply the product to the public 
sector. Some of the solutions that NASA has 
worked on and is working on now are described in 
the following paragraphs. 
The Lixiscope shown in Figure 10 is an excellent 
example of one of these projects. 
Figure 6. Heat Pipe Anchors The United States Coast Guard is attempting, 
71 
(COMPUTER SOmYARE MANAGEMENT AND INFORMATION CENTER) 
MAI#TrE#ANCE/USIER ASSISTANCE IS ALSO 
Figure 8. Cosmic Industrial Application Center 
to try to respond more quickly to harbor fires. 
What they were looking for is a lightweight, self- 
contained pump which can throw water farther and 
faster than most of their current pumps (Figure 1 1 ). 
In this case, they are looking for 2,000 gallons per 
minute in a stream reaching 200 feet. This is about 
double what they can do now (Figure 12). 
They would like to have the pump portable, to be 
transported by helicopter (Figure 1 3). 
The boat can go out to the fire, while in the mean- 
time, the fire fighting module can be picked up from 
the shore and carried to the boat, at the scene of the 
fire. 
The pump is now going into its final testing by the 
Coast Guard, hopefully it will be in service next year. 
While NASA was developing this prototype hard- 
ware for the Coast ~ u a r d ,  a manufacturer saw a 
commercial application and has put a different 
version of this kind of fire fighting equipment on the 
market. It is now on the market available for land 
fire fighting. 
Figure 14 is a picture of a bolt stress monitor which . 
is the final example to be presented. It wasdeveloped 
by NASA's Langley Research Center in Virginia and 
uses sound waves to give off a very highly accurate 
measure of the stress in' a bolt. Current torque 
testing of bolts is an inaccurate measurement 
because it doesn't take into consideration the 
friction between the threads and the nut. In this 
case, the system acts somewhat like measuring the 
sound of a violin string. The tighter you stress the 
violin string, the higher the pitch. 
The same principle applies here. Thus, the tighter 
you tighten the bolt, the more it stresses the bolt, 
which produces a different accoustical pitch. The 
instrument reads the accoustical signature and then 
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Figure 9. Technology Transfer to the Public Sector 
reads out the stress on the bolt. 
The preceding paragraphs have very briefly 
described the technology utilization program, the 
publications which are available for distribution, and 
the Industrial Applications Centers. Some programs 
were discussed which NASA developed to build 
prototype hardware to demonstrate that aerospace 
technology can be applied to public sector 
problems. ' 
The primary questions often asked of NASA are: 
"Does technology utilization pay off? Does this 
system you are working with benefit anybody? And if 
so, can you measure the benefit?" 
NASA commissioned Denver Research Institute 
Figure 10. Photograph of the Lixiscope last year to look at this method of transferring 
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technology. They identified users of the technology program, every tax dollar NASA spent in the 
and asked them to quantify the benefits. They technology utilization program to bring aerospace 
returned with an analysis that showed there was a technology to bear on problems in the private and 
six to one return on the taxpayer's investment. That public sector, there is a $6 return to the economy. 
is to say, for the entire technology utilization 
B. THE TECHNOLOGY UTILIZA"IB"0N PROGRAM AT GODDARD 
Mr. Donald S. Friedman 
Head, Technology Utilization Office 
Goddard Space Flight Center 
The Technology Utilization (TU) Program has its 
genesis from the Space Act, which says that NASA 
will disseminate information from its space activities 
in the widest possible manner. To accomplish this, 
the major elements are through publications, In- 
dustrial Applications Centers, and application proj- 
ects such as the Lixiscope. The TU Program is also 
involved in  program evaluations. 
To transfer this technology, GSFC is engaged in  a 
series of activities, as shown in  Figure 1. These 
include work in  space sciences, applications, manned 
space flight programs, basic space technologies, 
power systems and control system development, 
limited work in  energy with the Department of 
Energy, the tracking and data acquisition network at 
Goddard, and technology utilization. 
Basically, the Technology Utilization Program is a 
technology transfer program; that is, performing 
basic space activities, and then applying some of this 
technology in  a secondary application. One of these 
projects is the Lixiscope. 
The NASA policy on transferring technology is to 
identify the technology and pass it on. As part of this 
effort, it is necessary to identify its significance. One 
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Figurn 1 .  Activities for Technology Transfer 
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of the primary objectives is to work with manufac- 
turers to ultimately commercialize a particular 
product or project so it will get into the hands of the 
people and benefit the public. 
To accomplish this, NASA assists in but does not 
perform market studies, and assists and helps to 
identify and work with manufacturers. In addition, 
NASA works with many Federal institutions, and 
either looks for co-funding or co-funds certain 
projects for develpment. 
To illustrate NASAefforts in this regard, one project 
from the engineering spinoff that MASA started work 
on a few years ago, in collaboration with the Applied 
Physics Labs of Johns Hopkins Laboratory, was a 
rechargeable heart pacemaker shown in Figure 2. 
Johns Hopkins basically developed the pacemaker, 
Figure 2. Rechargeable Heart Pacemaker but some of NASA's space techndlogy was used, such 
as batteries, the electronics, and quality control 
techniques in the development. 
Figure 3 is a picture of the first person who had the 
pacemaker implanted. This photograph was taken on 
the fifth anniversary of the implant. What makes this 
pacemaker unique is the fact that it is rechargeable 
and the batteries do not have to be replaced. The 
photograph also shows Bob Fischell and Dr. Lewis. 
To continue this technology, GSFC is working with 
the Applied Physics Lab and the Johns Hopkins 
University on a device called the human tissue 
stimulator, which will be a rechargeable implantable 
device used to relieve pain as shown in Figure 4. This 
is another very good example of a spinoff. Figure 4 
also shows a command telemetry system, which was 
developed on one of our astronomy satellites by the 
Applied Physics Lab. The system can be tied right to 
the doctor's office, through telephone lines, to control 
the various parameters. The stimulator is planned to 
be used to relieve back pains and similar ailments. 
The preceding paragraphs have summarized some 
of the technology spinoffs of which GSFC has been a 
part. The Lixiscope represents another significant 
accomplishment in this regard. However, to find out 
more about the Technology Utilization Program, and 
what NASA is doing, NASA publishes a document 
entitled "Spinoff" which can be obtained from any 
Figure 3. Photograph of First Heart Pacemaker NASA ~ e c h n o l o ~ y  Utilization Office at the nearest 
Patient NASA Center. 
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Figure 4. Human Tissue Stimulator 
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v REGULATIONS PaLlcy  AFFECTING LIXISCOPE 
USE 
A. REGULATIONS CONCERNING RADIOISOTOPE PROCUREMENT & 
HANDLING & CLINICAL USAGE 
MEDICAL DEVICE AUTHORITY OF THE FOOD AND DRUG ADMINISTRATION 
Marshall S. Little 
Assistant Director for Standards and Regulations 
Division of Compliance 
Bureau of Radiological Health 
Food and Drug Administration 
Department of Health, Education, and Welfare 
The Food and Drug Administration (FDA) has 
responsibility for the regulation of electronic product 
radiation and also for medical devices. 
The authority over medical devices stems from the 
Food, Drug, and Cosmetic Act as it was recently 
revised by the 1976 Medical Device Amendments. 
The authority over electronic product radiation is 
derived from the Radiation Control for Health and 
Safety Act of 1968. 
The Radiation Control for Health and Safety Act 
authorizes the Agency to establish a radiation control 
program for electronic products. This program is 
focused primarily on the development of mandatory, 
as well as voluntary, radiation safety performance 
standards for the products. 
The Agency also has authority under this Act to 
take defect action against a manufacturer of a product 
which has a radiation safety defect that could cause a 
risk of injury, irrespective of whether there may be a 
radiation safety performance standard for that 
product. 
Under the Radiation Control for Health and Safety 
Act, the Agency has standards for television sets, 
microwave ovens, cabinet X-ray machines used in 
industry as well as the baggage X-ray devices 
available at airports, diagnostic X-ray equipment, 
laser products, ultrasound therapy, and cold cathode 
gas discharge tubes. Other standards nearing com- 
pletion are those for microwave diathermy, for mer- 
cury vapor lamps, and sunlamp products. 
To get into the authorities under the Food, Drug, 
and Cosmetic Act, it would be best now to look at the 
definition of a device as defined in that Act: 
DEFINITION 
1. An instrument, apparatus, implement, 
machine, contrivance, implant, in vitro 
reagent, or other similar or related article, 
including any component, part, or 
accessory 
2. lntended for use in thediagnosisof disease 
or other conditions, or in the cure, mitiga- 
tion, treatment, or prevention of dis- 
ease . . . or 
3. lntended to affect the structure or any 
function of the body . . . 
4. Does not achieve any of its principal in- 
tended purposes through chemical'action 
within or on the body. . . and . . . is not 
dependent upon being metabolized for the 
achievement of any of its principal intend- 
ed purposes. 
Figure 1. Definition of a "Medical Device" 
This definition was introduced into the Act through 
the recent Medical Device Amendments which were 
passed on May 28,1976. That date is quite important. 
It wil l  be referred to later on. 
Figure 2 is a list of authorities underthe Food, Drug, 
and Cosmetic Act. The first one authorizes the Agen- 
cy to classify or to categorize all of the existing 
medical devices into one of three classes: Class I 
being subject to general controls, Class II to perfor- 
mance standards, Class Ill to premarket approval. 
In other words, the higher the class, the more 
potential for injury or the more important in  terms of 
life support and medical care and, therefore, it would 
be subject to greater controls. 
0 Classification 
0 Pre-market Approval 
0 Registration and Listing 
0 Good Manufacturing Practices 
0 lnspections 
0 Biennial lnspections 
0 Detention 
0 Banned Devices 
0 Repair, Replace, or Refund 
0 Restricted Devices 
0 Presumption of Interstate Commerce 
Figure 2. FDA's New Medical Device Authority 
The pre-market approval would apply to the Class Ill 
devices. Manufacturers would be required to register 
their establishment and list their products. They 
would be subject to good. manufacturing practices 
regulations that would be issued by the Agency, and 
these regulations are about to be finalized. In fact, 
they were published in  final form recently and should 
become effective in December 1978. 
The Agency also has authority to inspect both the 
manufacturing facilities as wellas the using facilities 
and would be required to inspect all Class II and Class 
Ill manufacturing establishments every two years. 
The Field Inspectors would be authorized to detain 
medical devices suspected of being in violation of the 
Act for periods up to 30days without any court action. 
The Agency would have authority to issue regulations 
banning a device that had a substantial risk of injury 
or was deceptive. 
The authority'to require manufacturers to repair, 
replace, or refund the purchase price of a product 
could also be taken by the Agency under the new 
Medical Device Amendments; and the Agency could 
issue regulations establishing certain restrictions on 
the manufacture or use of products. The only two 
types of devices for which restrictions are imposed at 
the present time are hearing aids and prescription- 
type devices. 
And finally, there have been several court cases to 
determine whether a manufacturer was involved in 
interstate commerce, and the Agency could not take 
action unless that could be proven in  courts. Now, 
under the Medical Device Amendments, it is pre- 
sumed that interstate commerce is involved with 
respect to  any medical device. 
Some of the specific authorities of importance to a 
manufacturer of the Lixiscope include the following: 
Every manufacturer of a medical device must 
register with the Agency and provide a list of the 
report that is sent to the Agency. He must register 
annually. 
All devices are categorized into one of three levels, 
and the regulatory controls imposed on these levels 
would vary in the following way: Class I is subject to 
only the general controls such as prohibition on 
adulteration or misbranding, registration, and good 
manufacturing practices. The Agency could also re- 
quire a manufacturer to maintain certain records or 
submit reports. The regulations pertaining to restric- 
tions of devices or banning and so forth would also be 
part of the general controls. 
If a device falls into Class I!, this implies that a 
safety performance standard could be developed for 
the product and would eventually be mandatory. 
Class Ill would be subject to requirement that the 
manufacturer obtain pre-market approval prior to 
commercial distribution. 
The procedures for classificaiion are shown in 
Figure 3. 
First, there are 13 advisory, classification panels. 
They have reviewed all of the devices and have 
recommended to the Agency which class should be 
assigned to each device. 
CLASSIFICATION PROCEDURES 
1. Device Panel Makes Recommendation 
2. Federal Register Publication-Panel Re- 
port and Proposed Regulation classifying 
Device 
3. Federal Register Publication-Final Order 
Classifying Device 
*This starts the 30-month clock for Class Ill 
devices 
*At the end of 3 0  months, after publication of the final 
order for device classification, manufacturers must 
have filed a pre-market approval application or notice 
of completion of a product development protocol with 
FDA. Manufacturers may continue to market their 
devices during this 30-month period unless FDA 
declares otherwise. 
4. Federal Register Publication-Proposed 
Regulation Requiring Submission of Pre- 
market Approval Applications (For Class Ill 
Device) 
5. Federal Register Publication-Final Order 
Requiring Submission of Pre-market Ap- 
proval Applications (For Class Ill Device) 
*This starts the 90-day clock for Class Ill 
devices 
*At the end of 9 0  days. after publication of the final 
order for submission of PAAs, manufacturers must 
have filed a pre-market approval application or notice 
of completion of a product development protocol with 
FDA. Manufacturers may continue to market their 
devices during this 90-day period unless FDA 
determines otherwise. 
devices he manufac~ures. This is a relatively simple Figure 3. Classification Procedures 
Roughly 60 percent have been recommended for 
Class I, about 20 percent for Class II, and the 
remainder for Class Ill. 
These panel recommendations are now being 
considered by the Agency, and the Agency will then 
propose regulations i n  the FEDERAL REGISTER in  the 
very near future which would include the panel 
recommendation and the Agency proposed 
classification. 
In most cases, the proposed classification will 
agree with the panel recommendation, but in some 
cases, the Agency wil l  propose a classification dif- 
, ferent from the panel recommendation and wil l  so 
state the reasons for that difference. 
When these classification regulations are made 
final, the manufacturer may petition for a re- 
classification it he has information not previously 
considered by the panel or Agency. 
Class I devices are those for which general con- 
trols are sufficient or there is not adequate informa- 
tion to determine the full degree of possible risks as- 
sociated with the product; and they do not appear to 
represent an unreasonable risk. 
Class II devices are those for which there is suffi- 
cient information to develop a standard, or a stan- 
dard presently exists and can be made applicable to 
this product. 
Class Ill devices are those for which there is insuf- 
ficient information to assure safety and effective- 
ness either through standards or general controls. Its 
use is important to human life or health or it repre- 
sents an unreasonable risk of injury; or it is a device 
manufactured prior to the establishment of the 1976 
Medical Device Amendments, and is intended for 
surgicaj implants. All  surgical implants must be in 
Class 111 unless the Agency determines that pre- 
market approval is not necessary to  assure the safety 
and effectiveness. 
If is a device manufactured after May 28,1976, it 
is considered a new device and automatically falls 
into Class Ill unless the manufacturer can provide 
evidence that the device is substantially equivalentto 
a device manufactured prior to May 28, 1976. 
As mentioned previously, if the manufacturer feels 
that the classification of his device is for any reason 
an improper designation of a class and controls, he 
may petition for reclassification. This would have to 
be reviewed by one of the 13 Advisory Panels, and 
must be acted on by the Agency within 60 days. 
For all devices introduced into commerce for the 
first time after May 28, 1976, the manufacturer 
would have to notify the Agency at least 90 days prior 
to commercial distribution of the device. This pre- 
market notification is a relatively simple report sent to 
the Agency. 
The Agency has 90 days to act on that notification 
to determine whether the Agency agrees that it is 
substantially equivalent, in which case it would fall 
into the class already designated for that device. If the 
Agency determines that it is not substantially 
equivalentto a pre-1976 device, it automatically must 
fall into Class Ill and is subject then to pre-market 
approval. 
Figure 4 summarizes the type of information in- 
cluded in  the pre-market (or 510k) notification. 
A 510k Notification Must Include: 
1. Product Name (Proprietary and Common 
Names) 
2. Registration Number for Your Es- 
tablishment 
3. Class in  Which the Device is Classified 
4. Action Taken to Meet Performance Stan- 
dard or Pre-market Approval (Where 
Applicable) 
5. Labels, Labeling, or Advertisements that 
Describe the Device and Identify Its In- 
tended Use and Directions for Use 
6.  A Statement of How the Device is Similar 
to and Different from Other Devices on the 
Market 
7. For Changed or Modified Devices, Data 
Must be Included to Show How This 
Affects the Safety and Effectiveness of the 
Device (This Also Applies to Devices Being 
Marketed with a New or Different Use.) 
Figure 4. 51 0k Notification Information 
The Agency determines whether a device is 
equivalent to a device marketed prior to May 28, 
1976. If it is equivalent, it can be marketed. If it is not 
equivalent, then it is automatically subject to pre- 
market approval and falls into Class Ill. 
Then the manufacturer has certain alternatives. He 
can petition for reclassification, and that petition is 
then reviewed by the Advisory Panel to decide 
whether or not it is appropriate for Class Ill; he can file 
an investigational device exemption application if it is 
going to be used for investigational purposes on 
humans; or he can submit a pre-market approval 
application or a product development protocol. 
There is one other alternative not mentioned 
previously. If the manufacturer wants to use this 
device only for investigational purposes on animals 
and not humans, then he can so label the device and 
go ahead and distribute it forthat purpose, but it must 
be labeled not for use on humans. 
A pre-market approval application contains the 
information shown in Figure 5. 
1. For all Devices Classified in Class Ill 
2. Includes: 
0 Full Reports of All Data (Both Supporting 
and Adverse) 
@ Components, Ingredients, Properties, 
and Principle of Operation 
0 Manufacturing, Processing, Packing, 
and Installation lnformation 
0 Reference to Applicable Standards 
0 Samples of the Device 
0 Samples of the Labeling 
0 Other lnformation 
Figure 5. Pre-Market Approval-Applications 
This is for all devices classified in Class Ill, and that 
would include the "new" devices. The manufacturer 
must make available samples for evaluation by the 
Agency and samples of the labeling and other infor- 
mation that might be germane. 
There are alternatives to the pre-market approval. If 
a manufacturer does not want to submit the pre- 
market approval application or he  does not have the 
necessary information, he can submit a product 
development protocol, which is a plan to indicate in 
detail how the manufacturer intends to collect the 
information necessary to assure safety and effec- 
tiveness of the product. 
This is reviewed by the Agency, and if the Agency 
approves, the manufacturer begins collecting this 
information. When it is collected, the manufacturer 
submits a notification that he has completed his 
product development protocol. If the Agency agrees 
that the information is complete, the manufacturer 
may begin marketing the device. 
This has an advantage over the pre-market ap- 
proval, especially for something like the Lixiscope. 
because if the design of the device has not been 
rigidly fixed, it might be desirable to explore several 
different designs. The Agency is more likely to ap- 
prove the data once it is collected if it has previously 
approved the protocol. 
One could also obtain an investigational device 
exemption. This would be an exemption from any of 
the requirements of the Act'to allow distribution for 
use in investigations on humans. The regulations for 
the investigational device exemption have been 
published as a tentative final rule and probably will be 
finalized before the end of the year. There is a public 
hearing scheduled for August 7, 1978, on these 
regulations at Rockville, Maryland. 
Once the regulations become final, any in- 
vestigations of devices to determine safety and effec- 
tiveness on humans must be approved as prescribed 
in the new investigational device exemption 
regulations. 
How these regulations might apply to the Lixiscope 
device are as follows: - 
It has been indicated that there are two possible 
Lixiscope designs: one with the radioisotope source, 
the other with an X-ray tube. If it is manufactured 
with a radioisotope source, it is going to be subject to 
the licensing provisions of the Nuclear Regulatory 
Commission, or agreement states. 
As far as the FDA regulations, the manufacturer 
must submit a pre-market notification at least 90 days 
prior to his commercial distribution of the device. It is 
likely that it would fall into Class Ill, requiring pre- 
market approval because it is a unique device. 
It would also be desirable to obtain an in- 
vestigational device exemption to permit investiga- 
tion on humans. If the Lixiscope were designed with 
an X-ray tube, a pre-market notification also would be 
required. It is possible that the Agency would deter- 
mine that it is equivalent to devices that were on the 
market prior to  May 28, 1976, but this also is 
conjecture. 
There have been devices manufactured prior to 
May 28,1976 that use an intraoral X-ray tube. And, in 
fact, some are being marketed in the very near future. 
The FDA recently had a request for a variance from 
the diagnostic X-ray standard in order to manufacture 
these products. This brings up the point that the 
Lixiscope with an X-ray tube would be subject to the 
current diagnostic X-ray standard. It is doubtful that 
the product could meet all of the provisions of this 
standard. Thus, it would be necessary for the 
manufacturer to petition for a variance from that 
standard in order to be able to market it. 
LlCEMSlNG OF DEVICW WITH WADlOACTlVE SOURCES 
Dr. Leo Wade 
Chief of Medical and Academic Section, Radioisotopes Licensing Branch 
Nuclear Regulatory Commission (NRC) 
The Nuclear Regulatory Commission's authority to 
regulate the use of radioactive materialsderivesfrom 
the Atomic Energy Act of 1954, and a subsequent 
reorganization act which created the Nuclear 
Regulatory Commission when the Atomic Energy 
Commission was abolished. 
For any Lixiscope that does not utilize a radioactive 
source, that is, one that utilizes an X-ray tube, NRC is 
not involved in any way whatsoever, whether for 
human use or not. It is only those versions which 
might involve a radioactive source in  which the 
Nuclear Regulatory Commission is involved. 
The Nuclear Regulatory Commission regulates the 
possession and use of source material, special 
nuclear material, and by-product material; that is, 
radioactive material that can be produced as a by- 
product of a reactor. That includes iodine 125. There 
are some radioactive materials that the Nuclear 
Regulatory Commission does not regulate: naturally 
occurring radioactive materials such as radium, 
accelerator-produced radioisotopes such as cobalt 
57, and radiation-producing machines. 
The Nuclear Regulatory Commission also has the 
authority, as did the Atomic Energy Commission, to 
enter into agreements with state governments 
whereby the states assume some of the regulatory 
responsibility for certain radioactive material. This 
complicates the matter a little bit with respect to the 
Lixiscope because those states that have assumed 
the regulatory responsibility also regulate radium and 
accelerator produced radioisotopes and usually 
radiation producing machines. 
So the type and the exact nature of the regulations 
to which the manufacturer and the user of the Lix- 
iscope may be subjected depends upon whether it 
contains an X-ray source or a radioisotope source, 
whether it is to be used in  humans or not, and 
whether it happens to be used in  an agreement state 
or not. 
There are currently 25 agreement states, and so 
the odds are about 50/50 as to whether someone is 
regulated by the Nuclear Regulatory Commission or 
one of the states. 
A Lixiscope using 1-1 25 specifically would come 
under Nuclear Regulatory Commission regulations if 
the manufacturer were in a non-agreement state. If 
he were in an agreement state, it would come under 
state regulations but they would probably be pretty 
much equivalent. 
There are three types of licenses issued by the 
Nuclear Regulatory Commission. The first is a specific 
license of limited scope. This license may be issued by 
the Nuclear Regulatory Commission or by one of the 
agreement states for any type of specific use. It may 
include research and development, manufacturing 
and distribution, clinical evaluation of experimental 
devices, routine use of clinical devices and animal 
use. It is written specifically for a particular use and 
usually limits the type of radioactive material that can 
be used and specifically names the individuals that 
are authorized to use that radioactive material. This is 
the type of license that is held, for instance, by most 
medical institutions who use radioisotopes, either in  
drugs or in sealed sources for human diagnosis and 
'therapy. 
The second type of license for consideration is a 
specific license of broad scope. This may also 
authorize a number of uses, either human or non- 
human. The difference between it and the limited 
scope license is that the broad scope license normally 
authorizes a broad range of radioactive materials, and 
neither the users nor the uses are specifically 
designated. It is normally issued to institutions that 
have a lot.of experienced and well-trained people. 
The institution normally has a radioisotope com- 
mittee, consisting of people in various specialities 
with experience in  the use of radioactive material. 
That committee authorizes specific individuals to use 
the radioactive material. They take over part of the 
function of the Nuclear Regulatory Commission. They 
evaluate the individual's training and the specific 
uses for which the radioactive material wil l  be used. 
For example, such a license might authorize an 
institution for any radioactive material with atomic 
numbers from 3 to 83, and it would state that the 
users are to be designated by the radioisotope com- 
mittee. For authorized uses, it might say "research 
and development" or "me.dical research, diagnosis 
and therapy."These type of licenses may be issued to 
a large manufacturer or a large research firm. The 
Goddard Space Flight Center probably has a broad 
license of that type. Broad licenses are also issued to 
universities, to medical schools and to hospitals. 
The third type of license is a general license. A 
general license is one in which the regulations state 
that anyone is licensed to use a particular type of 
radioactive material, and it may subject them i o  
certain requirements, but an application is not 
required. Some types of general licenses require 
registration, but they do not require an application, 
and most do not require even a registration. 
For instance, there are general licenses for static 
elimination devices, certain measuring and gauging 
devices, luminous safety devices for aircraft, calibra- 
tion and reference sources, ice detection devices, and 
in vitro diagnosis of certain diseases. 
There is also one general license for in  vivo 
diagnostic procedures involving very small quan- 
tities. As an example of what might be conducted 
under any of these licenses, a manufacturing firm 
might manufacture and distribute an item such as a 
Lixiscope under either a specific license of limited 
scope or a broad license. Someone who would use 
the Lixiscope might do so under a license of limited 
scope or a license of broad scope. It is also possible 
that a Lixiscope could be used under a general 
license; that is, if the NRC saw fit to issue a general 
license for use of the Lixiscope. 
It would be unlikely that it would ever be used for 
human purposes under a general license. That is the 
author's personal speculation and not the agency 
position. 
A broad scope license, for example, would normally 
be issued to a medical school or a hospital and would 
be the type of license under which investigative 
protocols would normally be carried out. For example, 
the National Institute of Dental Research operates 
under a broad license issued tothe National Institutes 
of Health for human research, diagnosisand therapy. 
The University of Connecticut also holds a broad 
license for medical research, diagnosis and therapy. 
It is normally at institutions like this that clinical 
evaluations are carried out, although it is not ab- 
solutely required. A specific license could be issued 
for clinical evaluation. That is true for drugs and it is 
true for devices such as this that might contain sealed 
sources. 
The steps that might be required if the Lixiscope is 
ever to receive widerscale use wil l  be discussed in the 
following paragraphs. It should be noted that this 
concerns a Lixiscope that utilizes a radioactive 
source, not one that utilizes an X-ray tube. 
First of all, the manufacturer must hold a license 
either from the Nuclear Regulatory Commission or an 
, agreement state to even manufacture the instru- 
ment. There are several steps that could all be taken 
at once or could be taken sequentially. First, for 
instance, one might obtain a license for research and 
development of the Lixiscope; not for use at all, not for 
distribution or manufacture, but just for research and 
development. One application of that type has been 
submitted. 
The second step might be a license, after the 
research and development work was completed, for 
manufacturing and distributing the device. Assuming 
that distribution is to specific licensees, a license for 
manufacturing doesn't really require a lot more than 
a license for research and development other than an 
additional fee. 
But the third step that has to be taken either 
simultaneously or very close to the manufacturing 
and distributing license is a product evaluation. 
Whenever a specific license is issued to anybody to 
use a sealed source or device, that sealed source or 
device must be evaluated from the standpoint of its 
safety, not only to the individual using it, but to the 
general public. 
Rather than evaluate every one of these on an 
individual case, they are evaluated once. The infor- 
mation submitted by the manufacturer or the dis- 
tributor is evaluated so that when an individual or 
institution wants to use that sealed source or device, 
all of the information is in the files. The Nuclear 
Regulatory Commission knows that it has passed all 
of the necessary tests, that it is safe to use, and what 
special precautions might be needed to be imposed 
on the individual user. 
Concurrently with the manufacturing and dis- 
tributing license, there must be a submission to the 
Nuclear Regulatory Commission or to the agreement 
state of a description of the product and device. There 
may be one or two evaluations. For instance, some 
manufacturers may buy a sealed source as an off-the- 
shelf item from somebody and put it in their device 
and market it that way. In that case, the sealed source 
may have already been evaluated separately. 
In that case, however, the Nuclear Regulatory 
Commission would still have to evaluate the device 
containing the sealed source that is intended to be 
marketed. 
In some cases, the same manufacturer manu- 
factures the sealed source, puts it in the device, 
and it is sold as a unit. In that case, it would only be 
one product evaluation. But in either case, whether it 
is done in one step or two steps, the sealed source and 
the device both have to be evaluated. 
For evaluation of sealed sources, the Nuclear 
Regulatory Commission wants to know how it is 
going to be used, what it contains, how it is labeled, 
what type of encapsulation is around the sealed 
source, what type of testing it has been through to 
determine its integrity, and what type of quality 
control procedures are used. 
Basically, all these are from the standpoint of 
determining that it is safe for the user and does not 
present any hazard to the public in its use. 
For evaluation of the device, information is sought 
on things like radiation profilesand how i t  is installed. 
Is it something that is bolted to the floor or is'it 
something that is extremely portable? 
This leads to one of the potential problem areas of 
overlap between the Nuclear Regulatory Commission 
and the Food and Drug Administration, because the 
Food and Drug Administration is also involved in 
product evaluation. The two agencies are in  the 
process of negotiating a memorandum of understan- 
ding that may eliminate overlap between the two 
agencies and eliminate those areas where people 
might be subject to regulation by both agencies. 
An agreement is in  effect with the Food and Drug 
Administration for radioactive drugs. For many years, 
radioactive drugs were exempted from some of the 
Food and Drug Administration Regulations but now 
they have removed those exemptions, and as they did, 
the Nuclear Regulatory Commission backed out of 
certain areas in  drug evaluation and determination of 
the safety and efficacy. It is believed that most of the 
overlap has been eliminated in  those two areas. 
It is anticipated that a final memorandum of un- 
derstanding would operate in much the same way, 
and by knowing the function of the two agencies, one 
can take a guess at approximately where that dividing 
line might be. With respect tohareas of potential 
overlap, the primary responsibility of the Food and 
Drug Administration is the safety and effectiveness of 
the drug or device with respect to the patient, 
whether it is able to do whatthe manufacturer claims 
it can do, whether it is labeled properly, and that sort 
of thing. Simply, it deals primarily with safety to the 
patient. 
The Nuclear Regulatory Commission's responsi- 
bility, however, deals primarily with safey of the user 
and handler and the public. Now, that is an oversim- 
plification, and there is a lot to be negotiated 
between the two agencies and a lot that is difficult to 
understand and might take us a while to  work out 
between ourselves. In simplistic terms that is how 
such an agreement might finally take place. 
Now suppose the manufacturer has completed his 
research and development. He has obtained a license 
to do that. He has obtained a license to manufacture 
and distribute this device. NRC has completed its 
- product evaluation or, if the manufacturer is in  an 
agreement state, the agreement state has completed 
it; in  either case, information is exchanged so he 
doesn't have to go through this twice. But suppose all 
that is done and it is all ready to go. Unfortunately, he 
couldn't sell it because he has nobody to sell it to. He 
has nobody authorized to receive it. Sothat is the next 
step. Whoever wants to use it has to obtain a license 
to use it. 
Now assume that the user is an industrial firm who 
wants to use it for quality control or nondestructive 
testing. Then it is analogous to a lot of other types of 
licenses that the Nuclear Regulatory Commission 
has. He has to submit an application to the Nuclear 
Regulatory Commission, demonstrating that he has 
the training and experience that is necessary to use 
whatever it is that he wants to use and has im- 
plemented whatever controls may be appropriate. 
What that might mean depends upon the final form 
that the device might take. Once that individual user 
has submitted an application and received a license, 
then the manufacturer is free to sell to the user and 
no more is involved. If the user is located in an 
agreement state, the same thing would apply there. 
However, there is another possibility. It could be 
determined that sufficient controls can be published 
in the regulation so that the Commission feels that 
public health and safety could be adequately 
protected through a general license, and the Commis- 
sion could then conceivably issue a general license 
for its use. In this case, the individual users would not 
have to submit an application before they could use it. 
That type of license normally would require a petition 
for rulemaking to the Nuclear Regulatory Commis- 
sion, asking to place the device under a general 
license. It would then have to be evaluated in termsof 
the potential threat to the public health and safety. 
If it is just for industrial use, then that is all that is 
involved. If it is for medical use, however, there are a 
few more steps involved. If the user is a potential 
medical user wanting to use for clinical evaluation, he 
must meet all the FDA requirements, anda copy of his 
letter from the FDA saying that he has met their 
requirements should be submitted to the Nuclear 
Regulatory Commission. Once that is done, theh 
licensing would proceed just like for any other 
radioactive drug or any other device. For example, the 
University of Connecticut and the National Institute of 
Dental Research have broad licenses under which 
their own committees are enabled to approve 
protocols. Some restrictions are placed on those 
licenses, but not many. For instance, one of the 
restraints placed on those broad licenses says that 
any use of radioactive material in or on humans must 
be under the supervision of a physician. That would 
rule out the primary investigator being a dentist, for 
instance, if it were used on humans. That is not to say 
those things couldn't be changed. That is normally 
the way a license is issued now. But within the terms 
of their license, then these institutions are free, 
assuming they meet FDA requirements, to conduct 
their clinical evaluation. 
A hospital that did not have a broad license could 
apply for a specific license to do that clinical evalua- 
tion, in  which case the same question would be 
asked: Has the user met FDA requirements and 
submitted evidence that he has. If that evidence is 
submitted it would be evaluated strictly from a stand- 
point of the qualifications of the user: Does he know 2) To place it in  one of our designated groups. 
how to use radioactive material, whether it be this 
source or any other source, and have appropriate 
procedures been set up. If it is determined that he Most of the radioactive materials that are in 
had, then a specific license would be issued for that usage are divided into six groups, and one of 
clinical evaluation. these groups is a group for sealed sources. It includes 
As long as that individual user were a physician, it sealed sources for both diagnosis and therapy. 
is straightforward; however, if he is not a physician, a 
change to the regulations would be required. The If the LiXiscope is placed in that group, then all 
present regulations do not allow the use of radioac- those licensees who are already authorized for group 
tive material in or on humans by either a dentist or a six would automatically be authorized to use it, and 
podiatrist. they wouldn't have to submit any additional applica- 
Finally, assume that all the clinical evaluations had 
been completed and all FDA requirements had been 
met, and that approval had been given for distribution 
for routine use. There are two options to make its use 
widespread. Considering only medical uses, not den- 
tal or podiatry uses, there are two options: 
1 ) To issue a license to each individual physician or 
institution that wants to use the radioactive 
material. 
The preceding paragraphs gave a brief summary of 
the requirements. At this point it is not known which 
direction the Lixiscope is going, so it is complicated " 
because all potential options must be covered. As the 
device gets refined, and more definitive information is 
known about how it isgoing to be used and what form 
it wil l  take, then more definitive information can be 
provided about the regulatory requirements. 
B. PATENT POLICY & LICENSING 
John 0 .  Tresansky 
Patent Counsel's Office 
Goddard Space Flight Center 
Patent coverage on the Lixiscope and the NASA 
policy regarding licensing of private parties to prac- 
tice the Lixiscope invention will be discussed in the 
following paragraphs of this paper. To set the stage 
for NASA policy in this regard, it is necessary to go 
back about 20 years to when NASA was established 
after the Russians had launched their Sputnik. There 
was a lot of concern about the Russians getting the 
jump on the U. S. in  space. The Congress reacted 
uncustomarily rapidly by legislation which created 
NASA to conduct space exploration. In this legisla- 
tion, two concerns of Congress were rather evident. 
The first concern was Congressional fear that i n  this 
new area of technology there would likely be inven- 
tions resulting from the work being performed in the 
space exploration area, and Congress wanted to be 
assured that no particular segment of American 
industry would get a broad monopoly overthis field of 
space technology. 
So in the enacting legislation, the Congress pro- 
vided that any invention made relating to space and 
aeronautical activity sponsored by NASA belonged to 
the government. 
The second concern of Congress was that inven- 
tions resulting from the space exploration effort 
should benefit the American public whose taxdollars 
were paying for the efforts in space and aeronautics. 
So the legislation expressly authorized NASA to 
license inventions which resulted from space ex- 
ploration, and NASA has gone ahead for 20  years in 
implementing this Congressional provision. 
NASA, from its earliest days, has had patent licen- 
sing regulations which provide for the availability of 
inventions owned by NASA to be licensed either on a 
nonexclusive or on an exclusive basis. The patent 
licensing program is both domestic and foreign in its 
scope. Thus, NASA is in  a position to license both 
under U. S. patents and under foreign patents in 
those foreign countries i n  which NASA elects to file 
patent applications on our inventions. 
Generally speaking, NASA's inventions are initially 
made available on a nonexclusive basis, and only if 
there are no interested parties willing to undertake 
the risk involved in developing an invention for the 
marketplace on a nonexclusive basis wil l  the inven- 
tion become available on an exclusive basis. If there 
are some interested parties willing to undertake 
development on a nonexclusive basis but are un- 
successful within a particular time frame, these 
nonexclusive licensees are revoked and the invention 
is made available for licensing on an exclusive basis. 
Basically, this is the NASA licensing program. 
NASA recognized very early the commercial 
significance and potential of the Lixiscope invention, 
and quickly filed an application for patent in the 
United States Patent Office. This was filed in July 
1977. For those interested in obtaining licenses 
under it, the key information which is needed in  
applying for a license is given as follows: the NASA 
case number is GSC 12,263 and the patent number is 
4,142.1 01. 
NASA has received notice from the United States 
Patent Office that a patent wil l  be issued on the 
application. Now, for those of us who have been in  
this patent business for a long time, we remember the 
days not too long ago when it would take on the 
average of three and a half to five years to get a patent 
issued on an application. In fact, there was kind of a 
cynical truism uttered in the profession that if an 
invention is patented, it must be obsolete. 
However, in  this case a patent was issued in  about 
a year from the time the application was filed. The 
patent has 37 claims which define the scope of the 
patent monopoly in various degrees. The claims fall 
into two categories: 1 ) the structure of the Lixiscope, 
and 2) claims related to a method of radiation imag- 
ing. Both the apparatus and the process associated 
with its use are covered by the patent application. 
There is one peculiarity of the American patent 
system which should be noted. It is one that apparent- 
ly is not widely understood by the American public, 
including some in  industry. For some reason, the 
patent profession doesn't recognize the need to get 
this message across to American industry. Under the 
United States patent system, the granting of a patent 
only grants to the patentee.a negative right and not a 
positive right. The nature of this negative right is 
merely the right to exclude anyone else from making, 
using or selling the patented invention. Under U. S. 
patents, the patentee does not get the positive right to 
make, use or sell his invention. 
Thus, it should be understood by anyone interested 
in licensing under the Lixiscope patent that you are 
not free and clear of any possible patent infringement 
liability just because one obtains this license. This is 
not to say that any such liability exists.. 
Based on a review of the Patent Office prosecution, 
there does not appear to be any dominating patents 
covering the broad combination of structure involved 
in the Lixiscope. However, it is understood that the 
Lixiscope is primarily composed of a combination of 
commercially available components. 
If, in fact, any of these components which are 
utilized in the Lixiscope are covered by privately 
owned patents, anyone who wants to manufacture a 
Lixiscope must either procure that patented compo- 
nent from the patent owner or a licensee of the patent 
owner; or, in turn, procure from the patent owner a 
license to manufacture under the patent. It is nQt 
known whether or not the components used in the 
Lixiscope are privately patented. 
As a consequence, those who do become licensees 
under the patent on the Lixiscope wil l  notice in the 
license that NASA does not warrant that a licensee 
who practices, makes, uses or sells the Lixiscope, wil l  
be free of infringement liability. This is standard 
practice in U. S. patent licensing procedures. 
Six applications have been received from American 
corporations applying for nonexclusive licenses un- 
der the Lixiscope. As of now, the Lixiscope is only 
available for licensing on a nonexclusive basis and to 
date, NASA has granted four nonexclusive licenses. 
The four licenses are Electronic Relays Incorporated 
of Niles, Ohio; Pfizer Medical Systems f r ~ m  Colum- 
bia, Maryland; Narco McKesson Company of North 
Charleston, South Carolina; and IPCO Hospital Supp- 
ly Company from White Plains, New York. 
The earliest licensee is Electronic Relays of Niles, 
Ohio. Their license was granted in April of 1978. 
Thus, there has only been a short time period within 
which these licensees could apply efforts to develop 
the Lixiscope. 
In addition to the U. S. patent application, NASA 
has also filed patent applications in  13 foreign coun- 
tries. These countries are: Australia, Belgium, 
Canada, Denmark, Finland, France, Great Britain, 
Japan, Mexico, the Netherlands, Norway, Sweden, 
and West Germany. These applications were filed in 
November 1977. 
As part of NASA's patent licensing program, NASA 
also licenses under foreign patents. Normally, NASA 
makes foreign patents available for anyone in the 
world to license and manufacture abroad. However, 
in the case of the Lixiscope, NASA headquarters 
made a policy determination that licenses to 
manufacture, use and sell the Lixiscope in  any foreign 
country will be limited to U. S. industry. 
However, NASA wil l  license foreign industry under 
other patents to make, manufacture, and sell our 
inventions abroad. In the case of the Lixiscope, NASA 
will only license American manufacturers to 
manufacture and sell abroad. lnsofar as the American 
manufacturers are concerned, those American 
manufacturers who indicate that they are interested 
in  manufacturing the Lixiscope in the United States 
for sale and use abroad wil l  be given preferential 
consideration. This may be viewed as NASA's con- 
tribution to  re-establishing a favorable balance of 
payments situation. 
The key question is, "How does an American 
manufacturer apply for a nonexclusive license to the 
Lixiscope?" First, it is a rather simple process as far as 
the nonexclusive license is concerned. A standard % 
form, called Form 1495, must be filled out. The kind of 
information that Form 1495 seeks is as follows: 
1) describe the applicant's production and develop- 
ment capabilities; 2) identify the applicant's 
technical skills; 3) describe the applicant's marketing 
and distribution channels; and 4) identify the finan- 
cial resources that will be available for the further 
development of the Lixiscope. 
In regard to the financial resources, it is not 
necessary to disclose secret business or confidential 
information. In addition to the above information, 
NASA would like to know the applicant's plans and 
intentions as to the Lixiscope; such as what develop- 
ment and marketing are being contemplated, and the 
geographic areas for marketing. In other words, are 
you just interested in the northeastern market or the 
southwestern market? This information is desired 
because NASA wil l  grant nonexclusive licenses on a 
geographic basis. NASA would also like to know what 
technological fields of use of the invention are you 
particularly interested in? 
As far as the internal processing of any application 
or nonexclusive license is concerned, the application 
should be sent to the Patent Office at Goddard. It wil l  
be reviewed, a questionnaire wil l  be filled out and 
then it will be sent to NASA Headquarters, where, by 
statute, NASA's Inventions and Contributions Board 
is charged with the responsibility for passing on the 
question of whether or not the license should be 
granted or rejected. It is believed that nonexclusive 
licenses are granted to American corporations pretty 
e 
much as a matter of form. 
What are the conditions of the grant of a nonex- 
clusive license from NASA? lnsofar as an American 
corporation is concerned, NASA does not charge 
royalties, so the license is royalty free. The govern- 
ment wil l  realize its return from the employment 
opportunities that are created and the corporate taxes 
that are paid by a corporation manufacturing a 
Lixiscope. 
It should be pointed out again that the license grant 
does not warrant freedom from any patent infringe- 
ment. This is a responsibility that should be assumed 
by the commercial licensees. 
The license grant does require a licensee to submit 
annual reports on what progress has been made to 
bring the invention to the marketplace. Again, the 
primary interest is to get the inventions made with 
taxpayer dollars back to the taxpayers so they can 
realize the benefits resulting from the invention. 
The licenses are not assignable by the licensee. 
NASA requests that a licensee who is successful in 
developing a product for the marketplace indicate that 
the product was licensed by NASA. In turn, NASA 
prohibits the licensees from using the name of NASA 
or the name of the inventor for promotional purposes. 
NASA has to mairitain a neutral position i n  this area. 
Z To encourage licensees to be more expeditious in 
their efforts to bring the invention to the marketplace, 
the nonexclusive licenses usually set a target date for 
the licensee to get that invention to the marketplace. 
At this time, that target date is two years from the date 
of the grant. If the licensee is unsuccessful after that 
two-year period, NASA may revoke the license. 
Normally, a nonexclusive Ii2ense expires after 
seven years; however, it is understood that if there 
are cogent reasons to extend the license period, 
NASA will do so. Insofar as any revocation by NASA is 
concerned, NASA gives prior notice to licensees that 
revocation is being considered, thereby providing the 
licensees with an opportunity to come before the 
Inventions and Contributions Board to justify why the 
license should not be revoked. ' 
Finally, two questions are often asked by industry 
regarding licensing. These are: 1 ) Why it is that the 
government goes through the exercise of making its 
patents and inventions available initially on a nonex- 
clusive basis; and 2) What does a licensee get if he 
knows that he and anybody else can come in and 
obtain a nonexclusive license under a government 
patent? 
The answer to this is that the Justice Department, 
Antitrust Division, insists that inventions are made 
available on a nonexclusive basis initially. If that 
doesn't entice a company to invest risk capital to bring 
the invention tothe marketplace, the invention can be 
made available on an exclusive basis. Thus, thegrant 
of unnecessary exclusive monopolies is avoided, and 
in  a broad sense, a patent is a negative monopoly. 
What advantage is there for a manufacturer to 
come into NASA and request a nonexclusive license? 
First, by asking for a nonexclusive license, the 
manufacturer is assuring himself that some other 
manufacturer wil l  not get an exclusive license to 
practice the Lixiscope invention. This may happen if 
there are no applicants or no successfuI nonexclusive 
licensees. Second, it should be pointed out that the 
Lixiscope is in a rather early stage of development. 
When NASA grants a nonexclusive license, NASA 
does not require its licensees to grant back to NASA 
any rights under any improvement patents that the 
licensee may obtain. 
In other words, it is rather evident that im- 
provements are needed in  the Lixiscope to make it 
more commercially saleable. Any nonexclusive 
licensee who makes such an improvement can obtain 
a private patent on the improvement, and he alone 
owns that patent. The government gets nothing. 
Thus, a nonexclusive licensee of NASA may end up 
suing the government for infringement of his im- 
provement patent. 
In  closing, it should be pointed out that under the 
United States patent laws, patents can be obtained on 
in~provements i n  the Lixiscope design, as well as for 
some kind of unobvious application of the Lixiscope 
which may be developed by a nonexclusive licensee. 
Thus, one can obtain a patent for a new use of an 
existing device, and, if anyone, including the United 
States government, should use a Lixiscope for this 
new use, that nonexclusive licensee can hold the 
government to paying reasonable compensation. 
